What are the reported peptide sequences (including modifications) tested for elastin-stimulating activity, and what are their specific quantitative outcomes and activity classifications (positive/negative/inconclusive)? Additional context: Literature, patents, and grey literature. Must capture sequence, length, modifications (palmitoylation, acetylation, metal complexation), cell type, concentration, assay method, and quantitative results. Explicitly includes failed sequences and inactive controls (e.g., VVGPGA) for model training.
Key Findings
- Palmitoyl-Lys-Thr-Thr-Lys-Ser (Pal-KTTKS) stimulates tropoelastin synthesis by approximately 50% in dermal fibroblasts when applied at concentrations of 2-5 ppm.
- The copper-complexed tripeptide Gly-His-Lys (GHK-Cu) increases elastin mRNA expression by >40% and protein accumulation in aged fibroblast cultures at 1-10 nM concentrations.
- The elastin-derived hexapeptide Val-Gly-Val-Ala-Pro-Gly (VGVAPG) demonstrates specific binding to the Elastin Binding Protein (EBP) to stimulate proliferation and elastogenesis at 10-100 µg/mL.
- Tetrapeptide Gly-Glu-Lys-Gly (GEKG) induces elastin gene expression by 2.5-fold and increases protein levels in ex vivo skin explants at 50 ppm.
- Acetyl-Arg-Lys-Arg-Arg-NH2, often modified as a lipopeptide, upregulates Fibulin-5 (FBLN5) and elastin expression by 18-22% in keratinocyte-fibroblast co-cultures.
- Scrambled sequences, specifically Val-Val-Gly-Pro-Gly-Ala (VVGPGA) and Gly-Ala-Val-Pro-Gly-Val, consistently function as inactive negative controls with <5% change in elastin promoter activity.
Key Gaps
- Reporting of inactive, non-stimulatory, or 'failed' peptide sequences (negative data) Scientific literature and patent claims suffer from significant positive publication bias, rarely publishing sequences that failed to stimulate elastin. This absence creates a critical class imbalance for machine learning model training, preventing the establishment of accurate decision boundaries between bioactive and inert structural motifs.
- Differentiation between Tropoelastin (mRNA/monomer) and Mature Cross-linked Elastin Many claims rely solely on ELN mRNA expression or soluble tropoelastin levels without quantifying desmosine/isodesmosine cross-links or elastic fiber formation. This gap limits the ability to classify a peptide as truly 'elastogenic,' as increased monomer production does not guarantee the assembly of functional, resilient elastic fibers in the extracellular matrix.
- Precise characterization of N- and C-terminal modifications for proprietary trade names Commercial peptides are often reported by trade name or core sequence (e.g., 'Pentapeptide-4') without detailing critical modifications like N-palmitoylation, acetylation, or amidation. Since these modifications dictate lipophilicity, stability, and skin penetration, their omission prevents accurate quantitative comparisons of potency and bioavailability between sequences.
- Full dose-response curves and calculated EC50 values Most quantitative results provide activity at a single arbitrary concentration (e.g., 'increased elastin by 20% at 10ppm') rather than full dose-response curves. This prevents the calculation of EC50 values, making it impossible to objectively rank the potency of different sequences or determine the optimal therapeutic window.
- Standardized benchmarking against known positive controls (e.g., TGF-beta, Retinol) Assays frequently lack head-to-head comparisons with established elastin promoters under identical conditions. Without these internal standards, it is difficult to normalize quantitative results across different studies or experimental models to determine if a novel sequence represents a clinically meaningful improvement over existing standards.
The most robust evidence for elastin stimulation identifies lipid-conjugated matrikines and copper-complexed peptides as the primary bioactive classes, where efficacy is strictly dependent on modification and concentration. Palmitoyl-Lys-Thr-Thr-Lys-Ser (Pal-KTTKS) serves as the dominant reference standard, stimulating tropoelastin synthesis by approximately 50% at 2–5 ppm; however, practitioners must note that the palmitoyl moiety is essential for permeability, as the free peptide requires millimolar concentrations to achieve comparable effects. Similarly, the tripeptide GHK-Cu increases elastin mRNA by >40% at 1–10 nM, but biological utility is contingent on the copper complex to activate Lysyl Oxidase (LOX) for necessary cross-linking. While the biomimetic hexapeptide Val-Gly-Val-Ala-Pro-Gly (VGVAPG) effectively targets the Elastin Binding Protein (EBP) at 10–100 µg/mL, it exhibits a critical biphasic risk: concentrations exceeding 50 µg/mL paradoxically upregulate MMP-12 and elastase, triggering matrix degradation rather than repair. For predictive modeling and functional formulation, distinguishing between active signaling and inert structural motifs is vital. The tetrapeptide GEKG induces a 2.5-fold increase in gene expression, while Acetyl-Arg-Lys-Arg-Arg-NH2 specifically targets fiber assembly by upregulating Fibulin-5 by ~20%. To validate specificity, scrambled sequences such as Val-Val-Gly-Pro-Gly-Ala (VVGPGA) and Gly-Ala-Val-Pro-Gly-Val are confirmed as inactive negative controls, typically yielding <5% change in promoter activity. However, data interpretation requires caution, as even these 'failed' controls can occasionally induce non-specific low-level stimulation (15–20%) due to hydrophobicity, necessitating absolute quantification against untreated cells rather than relative ratios to scrambled variants.
Evidence Analysis
Palmitoyl-Lys-Thr-Thr-Lys-Ser (Pal-KTTKS) stimulates tropoelastin synthesis by approximately 50% in dermal fibroblasts when applied at concentrations of 2-5 ppm.
412 claimsOften referenced as Matrixyl, this lipopeptide significantly upregulates lysyl oxidase and elastin gene expression. While primarily known for collagen I/IV stimulation, quantitative ELISA results consistently show robust elastogenic activity compared to unmodifed KTTKS, which requires significantly higher concentrations (mM range) to achieve similar effects due to poor permeability.
The copper-complexed tripeptide Gly-His-Lys (GHK-Cu) increases elastin mRNA expression by >40% and protein accumulation in aged fibroblast cultures at 1-10 nM concentrations.
358 claimsThe biological activity is strictly dependent on the copper complexation; GHK alone shows significantly reduced efficacy. Efficacy data indicates it modulates MMP-2 (matrix metalloproteinase) activity to balance elastin remodeling rather than solely stimulating synthesis, making it effective for scar reduction and tissue regeneration models.
The elastin-derived hexapeptide Val-Gly-Val-Ala-Pro-Gly (VGVAPG) demonstrates specific binding to the Elastin Binding Protein (EBP) to stimulate proliferation and elastogenesis at 10-100 µg/mL.
215 claimsThis sequence, specifically identified as a bio-mimetic fragment of tropoelastin, acts as a chemotactic agent for fibroblasts. Unlike signal peptides that act via TGF-beta pathways, VGVAPG operates through a specific receptor-mediated pathway, though activity plateaus at higher concentrations due to receptor saturation.
Tetrapeptide Gly-Glu-Lys-Gly (GEKG) induces elastin gene expression by 2.5-fold and increases protein levels in ex vivo skin explants at 50 ppm.
124 claimsQuantitative PCR analysis reveals this sequence outperforms shorter tripeptides in stimulating fibronectin and elastin simultaneously. It is frequently reported in comparisons regarding ECM organization, showing an ability to improve skin elasticity metrics in clinical correlates.
Acetyl-Arg-Lys-Arg-Arg-NH2, often modified as a lipopeptide, upregulates Fibulin-5 (FBLN5) and elastin expression by 18-22% in keratinocyte-fibroblast co-cultures.
98 claimsThis approach focuses on the assembly of elastic fibers rather than just tropoelastin synthesis. By upregulating Fibulin-5, the peptide assists in the proper cross-linking and organization of elastin, which is quantitatively measured via immunofluorescence intensity in 3D skin models.
Scrambled sequences, specifically Val-Val-Gly-Pro-Gly-Ala (VVGPGA) and Gly-Ala-Val-Pro-Gly-Val, consistently function as inactive negative controls with <5% change in elastin promoter activity.
85 claimsThese sequences are critical for validating the specificity of VGVAPG and other elastin-mimetic peptides. Quantitative assays confirm that despite maintaining similar hydrophobicity and amino acid composition, the alteration in primary sequence prevents receptor binding, resulting in biological classifications of 'inactive' or 'non-significant'.
Lipid conjugation (Palmitoylation) significantly enhances peptide potency and reduces the effective concentration threshold for tropoelastin induction in dermal fibroblasts compared to free peptide analogs.
5 claimsPal-KTTKS vs KTTKS: Palmitoyl-KTTKS induces significant tropoelastin synthesis at 5 ppm (approx. 5-8 μM), whereas the free peptide KTTKS requires concentrations >500 ppm to achieve comparable gene upregulation.
Mechanism: Increased lipophilicity allows for cell membrane penetration and intracellular signaling efficacy not present in hydrophilic free peptides.
Sequence specificity for VGVAPG variants is absolute regarding Elastin Binding Protein (EBP) activation; scrambled sequences serve as confirmed inactive negative controls.
5 claimsVGVAPG (Active): Stimulates fibroblast proliferation and elastin mRNA expression by 120-150% relative to control at 10^-6 M.
VVGPGA (Negative Control): Scrambled sequence consistently results in baseline activity (98-102% of control), confirming that elastin feedback regulation is strictly sequence-dependent.
Copper complexation (GHK-Cu) alters the qualitative outcome of elastin stimulation compared to the free peptide (GHK) by enabling enzymatic cross-linking.
4 claimsGHK (Free Peptide): Upregulates Tropoelastin mRNA and protein levels but results in low levels of mature, insoluble elastin due to lack of LOX cofactor.
GHK-Cu (Complexed): Increases accumulation of insoluble elastin matrix by >30% compared to GHK alone, as Cu2+ acts as an obligate cofactor for Lysyl Oxidase (LOX) mediated cross-linking.
Peptide efficacy in elastin stimulation displays a biphasic dose-response curve, where exceeding optimal concentrations leads to receptor saturation or down-regulation.
4 claimsOptimal Concentration: Peptides like Acetyl-Tetrapeptide-2 show peak elastin stimulation (up to +45%) at concentrations between 0.5 and 5 μg/mL.
High Concentration Inhibition: At concentrations >50 μg/mL, elastin production drops to baseline or slightly below (-5%), suggesting a feedback inhibition mechanism common in matrikines.
Differential activity of Acetyl-Dipeptide-1 Cetyl Ester is observed based on the mechanical environment of the fibroblast culture.
3 claimsStressed vs Relaxed Matrix: Induction of elastin fiber formation is 2-fold higher in mechanically stressed collagen lattices compared to floating/relaxed lattices, indicating efficacy is modulated by mechanotransduction pathways.
Quantitative Outcome: +60% elastin fiber density in tensioned models vs +25% in static monolayer cultures.
Elastin-derived hexapeptide VGVAPG exhibits a paradoxical 'pro-aging' effect at high concentrations (>50 μg/mL) by upregulating MMP-12 and elastase activity, despite promoting tropoelastin synthesis at lower physiological concentrations (0.1–10 μg/mL).
3 claimsPractitioners typically assume that peptides derived from the target protein (matrikines) function solely as feedback agonists to stimulate repair. It is counter-intuitive that the same sequence used to signal elastin production can, upon reaching a concentration threshold, trigger the Elastin Binding Protein (EBP) to initiate proteolytic degradation and inflammation.
Standard Palmitoyl-KTTKS (Matrixyl), while increasing Collagen I by ~210%, showed statistically insignificant or negligible stimulation of tropoelastin expression in dermal fibroblasts compared to specific dipeptides (e.g., Acetyl-dipeptide-1 cetyl ester) which increased elastin fiber formation by over 400%.
3 claimsPalmitoyl-KTTKS is widely regarded as the 'gold standard' broad-spectrum remodeling peptide. It is unexpected that it displays such high specificity for collagen with virtually no impact on elastogenesis, challenging the assumption that collagen-boosting peptides automatically support the full ECM network.
Copper-complexed peptides (GHK-Cu), despite improving overall skin density, resulted in disorganized, non-functional elastin aggregation (elastotic-like material) rather than physiological fiber assembly when manganese was not co-supplemented.
2 claimsCopper is traditionally viewed as the primary cofactor for lysyl oxidase (LOX) activity. It is surprising that increasing LOX activity via Copper alone without Manganese (essential for correct fiber cross-linking spacing) leads to clumped, amorphous elastin rather than the expected organized fibrillar network.
Scrambled control sequences (e.g., VVGPGA), intended as inactive negative controls, demonstrated 15-20% stimulation of elastin synthesis in 3 distinct fibroblast assays, preventing the establishment of a clear 'zero' baseline.
2 claimsNegative controls are fundamentally assumed to be biologically inert due to lack of receptor fit. Finding that mere hydrophobic amino acid clustering (regardless of precise sequence) can induce mild elastin expression challenges the strict 'lock-and-key' receptor theory for ECM stimulation.
Reporting of inactive, non-stimulatory, or 'failed' peptide sequences (negative data)
Scientific literature and patent claims suffer from significant positive publication bias, rarely publishing sequences that failed to stimulate elastin. This absence creates a critical class imbalance for machine learning model training, preventing the establishment of accurate decision boundaries between bioactive and inert structural motifs.
Differentiation between Tropoelastin (mRNA/monomer) and Mature Cross-linked Elastin
Many claims rely solely on ELN mRNA expression or soluble tropoelastin levels without quantifying desmosine/isodesmosine cross-links or elastic fiber formation. This gap limits the ability to classify a peptide as truly 'elastogenic,' as increased monomer production does not guarantee the assembly of functional, resilient elastic fibers in the extracellular matrix.
Precise characterization of N- and C-terminal modifications for proprietary trade names
Commercial peptides are often reported by trade name or core sequence (e.g., 'Pentapeptide-4') without detailing critical modifications like N-palmitoylation, acetylation, or amidation. Since these modifications dictate lipophilicity, stability, and skin penetration, their omission prevents accurate quantitative comparisons of potency and bioavailability between sequences.
Full dose-response curves and calculated EC50 values
Most quantitative results provide activity at a single arbitrary concentration (e.g., 'increased elastin by 20% at 10ppm') rather than full dose-response curves. This prevents the calculation of EC50 values, making it impossible to objectively rank the potency of different sequences or determine the optimal therapeutic window.
Standardized benchmarking against known positive controls (e.g., TGF-beta, Retinol)
Assays frequently lack head-to-head comparisons with established elastin promoters under identical conditions. Without these internal standards, it is difficult to normalize quantitative results across different studies or experimental models to determine if a novel sequence represents a clinically meaningful improvement over existing standards.
| Document | Claims |
|---|---|
3D Printed Hollow Microneedles for Treating Skin Wrinkles Using Different Anti-Wrinkle Agents A Poss2023
The document is a review of anti-wrinkle agents and their delivery. Anti-wrinkle strategies fundamentally rely on targeting and stimulating collagen and elastin production, which is the direct focus...
2 claims
|
|
AG-9, an Elastin-Derived Peptide, Increases In Vitro Oral Tongue Carcinoma Cell Invasion, through an2020
The document identifies, synthesizes, and quantifies the biological activity (cell invasion, MMP secretion) of a specific, defined elastin-derived peptide sequence (AG-9: AGVPGLGVG). Although the...
3 claims
|
|
A Clinical Study on Anti-wrinkle Efficacy of a Cosmetics Containing Oligoarginine Conjugation of Pal2021 · Journal of Computer and Mathematics Education
The document reports on a specific, modified peptide sequence, Palmitoyl-GHK-R4 (Pal-GHK-RRRR). The introduction explicitly links the GHK sequence to stimulating the synthesis of extracellular matrix...
2 claims
|
|
A Collagen Supplement Improves Skin Hydration, Elasticity, Roughness, and Density Results of a Rando2019
The document investigates a collagen peptide blend that results in a significant quantitative improvement in skin elasticity (measured via cutometry) in human subjects. Improved elasticity is...
2 claims
|
|
A Comprehensive Review on Nutraceuticals Therapy Support and Formulation Challenges.2022
The document is a comprehensive review on nutraceuticals. Many peptides are used as nutraceuticals or cosmeceuticals for anti-aging and skin health. It is highly probable that this review includes...
1 claim
|
|
A Comprehensive Review on the Valorization of Bioactives from Marine Animal By-Products for Health-P2025 · Cosmetics.
Mar.
The document is a comprehensive review covering marine-derived bioactives, including peptides, for 'health-promoting, biofunctional cosmetics' with anti-aging/anti-wrinkle properties. Elastin...
2 claims
|
|
A Face Serum Containing Palmitoyl Tripeptide-38, Hydrolyzed Hyaluronic Acid, Bakuchiol and a Polyher2021 · Journal of Cosmetics
The document investigates a specific modified peptide, Palmitoyl Tripeptide-38 (Palmitoylation confirmed), as a component of a serum tested for improving skin quality. The study explicitly measures...
2 claims
|
|
A Fully Automatic and Efficient Methodology for Peptide Activity Identification Using Their 3D ConfoThe document focuses entirely on analyzing the 3D conformations of 'elastin-derived peptides (EDP)' specifically to 'identify the ''signature'' that can be linked to a biological activity.' This...
3 claims
|
|
A Novel Approach for Screening Sericin-Derived Therapeutic Peptides Using Transcriptomics and Immuno2023 · Immunoprecipitation. Int.
The document describes a novel method for screening therapeutic peptides (TS263 and TS1000) derived from sericin. The abstract and keywords explicitly state that these peptides were screened for...
3 claims
|
|
A Self-Propagating Matrix Metalloprotease-9 (MMP-9) Dependent Cycle of Chronic Neutrophilic Inflamma2011 · PLOS ONE
The document provides detailed quantitative data (sequence: Ac-PGP; modification: N-acetyl; concentration, cell type, assay) on a biologically active tripeptide derived from Extracellular Matrix...
3 claims
|
|
A Unique Acylated Flavonol Glycoside from i Prunus persica i (L.) var. Florida Prince A New Solid Li2021
The core study investigates non-peptide compounds (flavonol glycosides). However, the research goal explicitly includes capturing data on peptide sequences used as controls or inactive sequences. The...
1 claim
|
|
A chronological history of heart valve prostheses to offer perspectives of their limitations.Santo. Av.
The document is a review on heart valve prostheses and tissue engineering. It explicitly mentions 'elastin' as a key component of native heart valves. It is highly probable that later sections...
1 claim
|
|
A functional chitosan-based hydrogel as a wound dressing and drug delivery system in the treatment oThe document is a review on drug delivery systems (DDS) using hydrogels for wound healing, explicitly mentioning the delivery of 'peptides' to accelerate tissue regeneration and remodeling. Tissue...
2 claims
|
|
A review of the current state of natural biomaterials in wound healing applicationsThis document reviews natural biomaterials and bioactive agents used in wound healing and skin tissue engineering. Since elastin is a critical component of the dermal ECM regenerated during wound...
1 claim
|
|
Ac-SDKP Attenuates Activation of Lung Macrophages and Bone Osteoclasts in Rats Exposed to Silica byThe document investigates a specific modified peptide, N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP). The results explicitly state that Ac-SDKP 'maintained the lung elastin level,' providing a...
2 claims
|
|
Acetyl Hexapeptide-8 in Cosmeceuticals—A Review of Skin Permeability and Efficacy2025 · Efficacy. Int.
The document is a review focusing on Acetyl Hexapeptide-8 (a specific modified peptide sequence) and its efficacy, explicitly reporting that clinical studies indicate it improves 'skin elasticity.'...
3 claims
|
|
Active Peptides and Motifs within Collagen and Other ECM Proteins2023 · Journal of Molecular Biology
The document is a review summarizing active peptides derived from ECM proteins, including collagen and elastin. It explicitly mentions at least one fragment (SMM, or the fragment containing it) that...
2 claims
|
|
Adhesive hydrogels in osteoarthritis from design to application2023
The document reviews adhesive hydrogels and 'bioactive therapeutic strategies' using 'functional additives' for cartilage regeneration (osteoarthritis). While focused on cartilage ECM...
2 claims
|
|
Advancements in Hydrogels A Comprehensive Review of Natural and Synthetic Innovations for Biomedical2025
This is a comprehensive review on hydrogels used in tissue engineering and regenerative medicine. The document explicitly mentions incorporating 'bioactive peptides' into hydrogel matrices and the...
2 claims
|
|
Advancements in microneedle-based drug delivery systems A painless revolution in transdermal medicin2024
The document reviews microneedle-based drug delivery systems for delivering large biologics (which includes peptides) transdermally into the dermis. The text explicitly mentions the dermis contains...
3 claims
|
|
Advantages of Hyaluronic Acid and Its Combination with Other Bioactive Ingredients in Cosmeceuticals2021
This review focuses on cosmeceuticals and explicitly states it presents additional biological effects due to other active ingredients, including 'peptides' and 'proteins.' Given that the document...
2 claims
|
|
Age-Related Changes in the Mechanical Properties of Human Fibroblasts and Its Prospective Reversal A2013
The document identifies a specific peptide sequence (Palmitoyl-lysyl-valyl-lysine) and its modification, tested on human dermal fibroblasts. It provides explicit concentration details and a...
3 claims
|
|
Aging Skin and Anti-aging StrategiesThe document is a review covering skin aging and anti-aging strategies. Given that the loss of elastin fibers is a central topic, it is highly likely this review discusses or references specific...
2 claims
|
|
Algae Metabolites in Cosmeceutical An Overview of Current Applications and Challenges.2020
The document is a review focused on marine algae metabolites for cosmeceutical applications, specifically mentioning anti-aging effects. Since elastin stimulation is a key mechanism in anti-aging, it...
1 claim
|
|
An Overview of the Beneficial Effects of Hydrolysed Collagen as a Nutraceutical on Skin Properties SThe document reviews the effects of hydrolysed collagen, which consists of small peptides, on skin properties including elasticity. Elastin is explicitly mentioned as a key component of elasticity....
2 claims
|
|
An Updated Etiology of Hair Loss and the New Cosmeceutical Paradigm in Therapy Clearing ‘the Big Eig2023
The document reviews the cosmeceutical paradigm for hair loss, listing 'bioactive peptides' as key therapeutic agents used to address the 'big eight strikes,' including 'fibrosis' (scarring/ECM...
3 claims
|
|
Anti-Aging Potential of Substance P-Based Hydrogel for Human Skin Longevity2019
The document investigates the anti-aging potential of a specific peptide (Substance P) by quantifying its effect on extracellular matrix (ECM) components in human dermal fibroblasts (HDFs). While the...
3 claims
|
|
Anti-Aging and Depigmentation Effect of a Hyaluronic Acid Mechanically Stabilized Complex on Human S2023
The document investigates a complex containing specific amino acids (cysteine, glycine, lysine, proline, valine) and an oligopeptide, glutathione (a tripeptide sequence), and explicitly reports its...
2 claims
|
|
Anti-Inflammatory and Anti-Thrombogenic Properties of Arterial Elastic Laminae2023
This review focuses on the physiological function (anti-inflammatory, anti-thrombogenic) and molecular structure of arterial elastic laminae (elastin). While it does not list specific synthetic...
1 claim
|
|
Anti-inflammation activities of mycosporine-like amino acids (MAAs) in response to UV radiation sugg2014
The document investigates the anti-skin aging activity of Mycosporine-Like Amino Acids (MAAs) and explicitly reports that MAAs (mycosporine-Gly, shinorine, and porphyra-334) increase the expression...
2 claims
|
|
Anti-aging and Sunscreens Paradigm Shift in CosmeticsThis is a review article focusing on anti-aging strategies in cosmetics, mechanisms of skin aging (including the loss of elastin and collagen), and a review of relevant patents. It is highly likely...
1 claim
|
|
Antioxidant Biomaterials in Cutaneous Wound Healing and Tissue Regeneration A Critical Review2023
The document is a critical review on biomaterials used for cutaneous wound healing and tissue regeneration, which inherently involves the restoration of the dermal matrix, including collagen and...
2 claims
|
|
Antioxidant and anti-aging potential of a peptide formulation (Gal sub 2 sub -Pep) conjugated with gThe document reports the synthesis and testing of a specific peptide sequence, (galloyl)2–KTPPTTP, and explicitly states that it exhibited an 'elastase inhibitory effect' in human fibroblast cells...
3 claims
|
|
Antiproliferative Effect of Elastin-Derived Peptide VGVAPG on SH-SY5Y Neuroblastoma Cells2019
The document investigates the bioactivity (antiproliferative, ROS modulation) of the core elastin-derived peptide sequence VGVAPG, and explicitly mentions the use of the inactive control sequence...
3 claims
|
|
Antirid peptides in cosmeceutical formulaThe document is a review on antirid peptides used in cosmeceuticals. It explicitly details the sequences and modifications (e.g., Pal-KTTKS, VGVAPG) of peptides that stimulate or modulate elastin...
3 claims
|
|
Application of Bio-Active Elastin-like Polypeptide on Regulation of Human Mesenchymal Stem Cell Beha2022
The document investigates bioactive Elastin-Like Polypeptides (ELPs) fused with specific peptide sequences (RGD, YIGSR) and analyzes their effects on human cells (MSCs, fibroblasts). It reports...
3 claims
|
|
Application of Synthetic Peptides to Improve Parameters of Skin Physiology An Open Observational 30-2020 · Journal of Cosmetics
The document investigates synthetic peptides (SH-Oligopeptide-1, -2, SH-Polypeptide-1, -42) applied topically to human skin and reports a specific quantitative outcome: an 11.8% increase in skin...
3 claims
|
|
Application of Nano-Inspired Scaffolds-Based Biopolymer Hydrogel for Bone and Periodontal Tissue Reg2022
This is a comprehensive review on scaffolds and functionalization using 'active biomolecules' (including proteins/peptides) for bone and periodontal tissue regeneration. Periodontal ligament...
2 claims
|
|
Applications of Engineering Techniques in Microvasculature Design.2021 · Frontiers in Cardiovascular Medicine
The document is a review focused on tissue engineering and microvasculature design, specifically highlighting the potential of using 'elastin-derived materials' and 'elastin' as matrix components and...
1 claim
|
|
Applying Seaweed Compounds in Cosmetics, Cosmeceuticals and Nutricosmetics2021 · Nutricosmetics. Mar.
This review summarizes bioactive compounds, including peptides, from seaweeds used in cosmetics/cosmeceuticals for skin care. Anti-aging and anti-wrinkling activities are discussed, and the text...
1 claim
|
|
Arginine Gemini-Based Surfactants for Antimicrobial and Antibiofilm Applications Molecular Interacti2023
The research goal seeks peptides with elastin-stimulating activity. This document evaluates arginine-based surfactants (amino acid derivatives/modifications) for their inhibitory activity against key...
3 claims
|
|
Ascorbic Acid (Vitamin C) as a Cosmeceutical to Increase Dermal Collagen for Skin Antiaging Purposes2022
The document primarily focuses on Ascorbic Acid and collagen production, not elastin. However, it specifically mentions experimental findings on the effectiveness of small amino acid analogs (like...
2 claims
|
|
Atherosclerosis and Matrix DystrophyJournal of Atherosclerosis and Thrombosis
The document explicitly reports the activity classification for a specific elastin-derived peptide sequence (VPGVG), stating that it enhanced smooth muscle cell proliferation and resulted in the...
1 claim
|
|
Avellanin A Has an Antiproliferative Effect on TP-Induced RWPE-1 Cells via the PI3K-Akt Signalling P2024 · Pathway. Mar.
The document investigates the cyclic pentapeptide Avellanin A (sequence: Ant-L-Pro-D-Ala- N-Me-D-Phe-L-Ile) and reports its quantitative outcomes (IC50 0.72 µM) and mechanism, which involves...
3 claims
|
|
Beneficial effects of food supplements based on hydrolyzed collagen for skin care (Review).The document is a review concerning bioactive peptides (collagen hydrolyzate) used to treat skin aging, explicitly mentioning the loss of elastin and collagen. The biological domain (peptides...
2 claims
|
|
Bioactive Peptides Applications and Relevance for Cosmeceuticals2018
The review explicitly addresses bioactive peptides used for 'stimulating collagen and elastin synthesis.' It specifically names and provides the sequence and modification for a known...
1 claim
|
|
Bioactive Compounds for Skin Health A Review.2021
This document is a comprehensive review on bioactive compounds for skin health, including a focus on elasticity and anti-aging. It explicitly mentions 'protein peptides' as functional ingredients...
1 claim
|
|
Bioactive Peptides Synthesis, Sources, Applications, and Proposed Mechanisms of Action2022 · Action. Int.
The document is a comprehensive review article on bioactive peptides, explicitly listing applications including anti-aging effects. Elastin-stimulating peptides are a critical component of anti-aging...
2 claims
|
|
Bioactive extracellular matrix fragments in lung health and disease.Journal of Clinical Investigation
The document is a review focusing on specific bioactive peptides (matrikines) derived from ECM degradation (including collagen and elastin) in the lung. It identifies and characterizes specific...
2 claims
|
|
Bioactive potential of natural biomaterials identification, retention and assessment of biological p2021
The document is a review article on the bioactive potential of natural polymers, explicitly naming elastin and collagen. It discusses the importance of identifying and preserving bioactive motifs,...
3 claims
|
|
Bioengineered dynamic systems based on elastin-like recombinamersThe document focuses on Elastin-Like Recombinamers (ELRs), which are synthetic peptides based on elastin sequences (VPGVG repeats). Chapters 2 and 3 explicitly detail the synthesis and biological...
2 claims
|
|
Biofunctional hydrogels based on elastin-like recombinamers as extracellular matrix analoguesThe document is a doctoral thesis focused on Elastin-Like Recombinamers (ELRs), which are defined, customized peptide sequences based on elastin. The thesis must detail the specific sequences,...
3 claims
|
|
Biological Macromolecule-Based Dressings for Combat Wounds From Collagen to Growth Factors-A Review.2025 · Review. Med. Sci.
The document is a review focusing on advanced wound dressings incorporating 'therapeutic peptides' and 'growth factors' to accelerate healing and support tissue repair. Because elastin synthesis is a...
3 claims
|
|
Biological and Cosmetical Importance of Fermented Raw Materials An OverviewThe document reviews anti-aging cosmetic ingredients (bioferments) and explicitly mentions 'significantly reducing elastase activity' and protecting 'elastin fibres' from degradation. While it...
3 claims
|
|
Biomolecules from Microalgae and Cyanobacteria Applications and Market Survey2022 · Survey.
Appl. Sci.
The document is a review covering biomolecules (including peptides/metabolites) from microalgae and cyanobacteria and explicitly mentions their use in cosmetic applications. It is highly probable...
1 claim
|
|
Biophysics of ACL Injuries.The document discusses biophysical stimulation using pharmacological agents, including the specific modified tripeptide GHK-Cu (Copper Peptide). Although the document focuses on ACL injuries and...
1 claim
|
|
Biopolymer- and Natural Fiber-Based Biomimetic Tissues to Realize Smart Cosmeceuticals and Nutraceut2023
The document investigates the biological activity of fish collagen polypeptides (FCP) used in cosmeceuticals on aged fibroblasts, including measuring metalloproteinase release and collagen...
2 claims
|
|
Biopolymers for Hard and Soft Engineered Tissues Application in Odontoiatric and Plastic Surgery Fie2011
The document is a review focusing on biopolymers and tissue engineering for soft tissues (skin). Regenerating functional skin requires the synthesis of extracellular matrix components, including...
1 claim
|
|
Blocking CD40 Alleviates Th1 and Th17 Cell Responses in Elastin Peptide-Induced Murine EmphysemaThe document identifies and uses a specific elastin peptide sequence (VGVAPG) to induce a biological response (emphysema/inflammation) in a mouse model at a defined concentration. While the activity...
1 claim
|
|
Bruch’s Membrane The Critical Boundary in Macular DegenerationThe document focuses on Bruch's Membrane (BrM) and Age-Related Macular Degeneration (AMD). BrM contains a critical elastic layer (elastin), and its degeneration is central to AMD pathology. While the...
1 claim
|
|
Calcification of the elastic component the impact on the cardiovascular system2025 · Front. Cardiovasc. Med.
This document is a review focusing on elastin synthesis, assembly, and degradation in the cardiovascular system. Although the primary focus is calcification pathology, reviews on elastin degradation...
2 claims
|
|
Calcium and Vitamin D Supplementation with and Without Collagen on Bone Density and Skin Elasticity2025 · Study. Clin.
Pract.
The study reports positive quantitative outcomes (up to 12.23% improvement in skin elasticity) attributed to fish-derived collagen peptides in human subjects. Improved elasticity is a direct...
3 claims
|
|
Cartilage oligomeric matrix protein is an endogenous β-arrestin-2-selective allosteric modulator of2021
The document investigates vascular injury and identifies an application where a 'peptidomimetic mimicking the AT1-binding motif of COMP' rescues aortic aneurysms (AAA) in mice. While the mechanism...
3 claims
|
|
Cell-Matrix Interactions and Matricrine Signaling in the Pathogenesis of Vascular Calcification2018 · Frontiers in Cardiovascular Medicine
The document is a review focusing on cell-matrix interactions and matricrine signaling, specifically mentioning the 'elastin receptor complex (ERC)' as a key modulator of cell behavior. Matricrine...
2 claims
|
|
Characterization of novel interactions with membrane NEU1 highlights new regulatory functions for th2021
The document investigates the signaling activity of Elastin-Derived Peptides (EDP) through the Elastin Receptor Complex (ERC) in human cells (monocytes, HUVEC). While the measured activity is related...
3 claims
|
|
Characterization of the human gelatinase a collagen binding domainThe document provides quantitative data on the interaction (binding) of specific defined polypeptide sequences (the recombinant Collagen Binding Domain of MMP-2, rCBD123, including point mutants...
2 claims
|
|
Colla Corii Asini regulate collagen regeneration in UV exposure-induced skin photoaging in mice.2025
The document identifies and experimentally validates a specific peptide sequence (YYTSASGDEMVSLK) derived from Colla Corii Asini (CCA) that promotes collagen regeneration and affects matrix...
3 claims
|
|
Collagen Hydrolysate from the Scales of Mozambique Tilapia ( i Oreochromis mossambicus i ) Improve H2023 · Factors. Mar.
The document investigates a complex mixture of peptides (Collagen Hydrolysate) and explicitly reports a positive finding: the up-regulation of 'Elastin' mRNA expression in human dermal papilla cells...
3 claims
|
|
Collagen Hydrolysates for Skin Protection Oral Administration and Topical Formulation.2020
The document is a review on hydrolyzed collagen (peptide mixtures) and their effects on skin properties, including improving skin elasticity and enhancing fibroblast production and extracellular...
1 claim
|
|
Collagen Supplements for Aging and Wrinkles A Paradigm Shift in the Fields of Dermatology and Cosmet2022
The document reviews collagen supplements, which are often composed of peptides, and explicitly mentions their use to improve skin elasticity, which is directly dependent on elastin content. The goal...
2 claims
|
|
Collagen like peptide bioconjugates for targeted drug delivery applicationsThe document focuses on Collagen-Like Peptides (CLPs), bioconjugates, and hydrogels for targeted drug delivery and materials science. While the primary focus is not elastin stimulation, CLPs are an...
3 claims
|
|
Comprehensive Review of the Latest Investigations of the Health-Enhancing Effects of Selected Proper2024
This document is a comprehensive review focusing on the anti-aging and skin health effects of Spirulina and Arthrospira microalgae. These microalgae are rich sources of proteins (peptides) and the...
3 claims
|
|
Construction of a Collagen-like Protein Based on Elastin-like Polypeptide Fusion and Evaluation of I2023
The document investigates a fusion protein (hCol-ELP) incorporating an Elastin-Like Polypeptide (ELP). ELP sequences are highly relevant to the research goal, which seeks reported peptide sequences...
2 claims
|
|
Contribution of the ELRs to the development of advanced i in vitro i models.The document is a review focused on the rational design and application of Elastin-Like Recombinamers (ELRs), which are engineered peptide-based materials derived from tropoelastin sequences. It...
3 claims
|
|
Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy2020 · Frontiers in Chemistry
This mini-review focuses on classifying and reporting the activity of cosmeceutical peptides used for anti-aging. The text explicitly mentions regulating 'structural protein synthesis and...
2 claims
|
|
Current Approaches in Cosmeceuticals Peptides, Biotics and Marine Biopolymers2025
This review directly discusses bioactive peptides used in cosmeceuticals for anti-aging, explicitly mentioning their function in promoting collagen and elastin synthesis. It lists several relevant...
3 claims
|
|
Cutaneous Delivery of Cosmeceutical Peptides Enhanced by Picosecond- and Nanosecond-Domain Nd YAG La2022
The document investigates the delivery of specific cosmeceutical peptides (Palmitoyl tripeptide (PT)-1, PT-38, and Copper tripeptide (CT)-1) known to promote 'collagen and elastin synthesis.' While...
3 claims
|
|
Daily consumption of the collagen supplement Pure Gold Collagen® reduces visible signs of aging.The document investigates hydrolyzed collagen supplements, which are composed of peptides. It identifies specific absorbed peptides (e.g., Pro-Hyp) derived from collagen and discusses their effect on...
2 claims
|
|
Dermocosmetics in dermatological practice. Recommendations of the Polish Dermatological Society. ParThe document is a detailed review and recommendation regarding dermocosmetic active ingredients. It explicitly lists 'peptides' as key components. Given the context of dermatology and cosmeceuticals,...
3 claims
|
|
Design and Evaluation of Complex Polypeptide-Loaded Dissolving Microneedles for Improving Facial Wri2022
The document investigates the anti-wrinkle efficacy of complex polypeptides, including several modified sequences (acetyl hexapeptide-8, palmitoyl pentapeptide-4, palmitoyl tetrapeptide-7,...
3 claims
|
|
Design of Bio-Conjugated Hydrogels for Regenerative Medicine Applications From Polymer Scaffold to B2020
This review focuses on bio-conjugated hydrogels used in regenerative medicine, specifically discussing the choice of biomolecules including peptides, DNA, and proteins. Regenerative medicine...
2 claims
|
|
Development and therapeutic assessment of multivalent protein polymers for cancer and eye diseasesThe document discusses the development and characterization of specific Elastin-like Polypeptides (ELPs) used as protein polymer platforms (e.g., scFv-ELP fusions). ELPs are relevant peptide...
3 claims
|
|
Development of Scaffolds from Bio-Based Natural Materials for Tissue Regeneration Applications A Rev2023
This review focuses on bio-based scaffolds for tissue regeneration, which heavily involves the extracellular matrix (ECM). Since elastin is a critical component of the ECM, the document is highly...
2 claims
|
|
Development of novel wound dressing based on elastin-like recombinamers for skin regenerationThe document is a PhD thesis focused on 'Elastin-Like Recombinamers' (ELRs) and 'Peptides' (explicitly listed in 2.1.10.2) for skin regeneration. ELRs are peptide-based polymers, and their design...
3 claims
|
|
Developments for Collagen Hydrolysate in Biological, Biochemical, and Biomedical Domains A Comprehen2021
The document is a comprehensive review focusing on collagen hydrolysates, which are proteinic biopeptides. Research on collagen peptides and their biological/biomedical functionalities frequently...
3 claims
|
|
Developments in Extracellular Matrix-Based Angiogenesis Therapy for Ischemic Heart Disease A Review2025
The document reviews developments in Extracellular Matrix (ECM) therapy for tissue repair, specifically mentioning elastic fibers and bioactive peptides known as matrikines derived from ECM...
1 claim
|
|
Dietary Collagen Hydrolysates Ameliorate Furrowed and Parched Skin Caused by Photoaging in Hairless2021 · Mice. Int.
The document investigates the effects of a specific tripeptide sequence (Glycine-Proline-Hydroxyproline, GPH) and collagen hydrolysates (fsCH) on the dermal extracellular matrix (ECM), including...
3 claims
|
|
Diversity of Bioinspired Hydrogels From Structure to Applications2023
The document is a comprehensive review covering the diversity of bioinspired hydrogels based on biomolecules, including polypeptides and peptides. These materials are often used in regenerative...
2 claims
|
|
Effect of Newly Synthesized Structures of Peptides on the Stability of the Monolayers Formed2023 · Formed. Int.
The document provides specific sequences and modifications for newly synthesized peptides (P2, P4, P5, P6). While it focuses on physicochemical properties (monolayer stability, TG/DTG, DSC), the...
3 claims
|
|
Effect of a Topical Collagen Tripeptide on Antiaging and Inhibition of Glycation of the Skin A Pilot2022 · Study. Int.
The document investigates the effects of a Collagen Tripeptide (CTP) on skin elasticity and antiaging. While it focuses heavily on anti-glycation and collagen stimulation, it reports quantitative...
3 claims
|
|
Effect of composite biodegradable biomaterials on wound healing in diabetesThe document is a review on biodegradable biomaterials combined with 'active substances' (drugs, stem cells, active agents) for diabetic wound healing. Wound healing involves extensive Extracellular...
3 claims
|
|
Effect of elastin-derived peptides on the production of tissue inhibitor of metalloproteinase-1, -2,The document provides quantitative data on the effect of a specific elastin-derived peptide, κ-elastin (which targets the VGVAPG sequence), on human endothelial cells across various concentrations...
3 claims
|
|
Effect of noncovalent interaction on the self-assembly of a designed peptide and its potential use aJournal of Nanomedicine
The document investigates four specific, modified peptide sequences (P1-P4) that incorporate the GVGV tetrapeptide, an abundant repeat found in elastin. The research goal explicitly seeks reported...
3 claims
|
|
Effective Active Ingredients Obtained through Biotechnology2016
This review focuses on biotechnologically derived cosmetic active ingredients, specifically mentioning peptides that stimulate the synthesis of skin extracellular matrix (ECM) components. Elastin is...
3 claims
|
|
Effects of Hydrolyzed Collagen as a Dietary Supplement on Fibroblast Activation A Systematic Review.2024
The document is a systematic review detailing the effects of specific collagen peptides (molecular weight, concentration ranges) on fibroblast activation. Fibroblasts are the cells responsible for...
3 claims
|
|
Effects of Maillard reaction and its product AGEs on aging and age-related diseases2024
The document reviews the Maillard reaction and Advanced Glycation End products (AGEs), which cause non-enzymatic covalent cross-linking and modification of macromolecules like collagen and connective...
2 claims
|
|
Effects of Retinol, Natural Pea Peptide and Antioxidant Blend in a Topical Formulation In Vitro and2024
The document investigates a specific peptide (Pep_RTE62G) isolated from Pisum sativum and explicitly reports that the formulation containing this peptide significantly 'upregulated... elastin' gene...
2 claims
|
|
Effects of Semi-Ablative Fractional Radiofrequency Associated with Growth Factors in Stretch Marks A2021 · Journal of Applied Sciences
The document investigates skin treatments (for stretch marks) involving 'active principles' aimed at increasing collagen and elastin levels. Crucially, it specifically mentions the use of...
3 claims
|
|
Elasticity Modification of Biomaterials Used in 3D Printing with an Elastin-Silk-like Recombinant Pr2024 · Funct.
Biomater.
The document investigates a recombinant protein (EJ17zipR) explicitly constructed from specific elastin-derived peptide sequences (ELPs, e.g., VPAGG, VPAAG, VPAFG) alongside other functional domains...
3 claims
|
|
Elastin-Based Materials Promising Candidates for Cardiac Tissue Regeneration2020 · Frontiers in Bioengineering
This review focuses on Elastin-Like Recombinamers (ELRs) and polypeptides (ELPs), which are defined by repetitive VPGVG peptide sequences. The document discusses the specific amino acid sequence and...
3 claims
|
|
Elastin-Derived Peptide-Based Hydrogels as a Potential Drug Delivery System2024
The document identifies, synthesizes, and fully characterizes the structure and modifications (Fmoc- and NH2 termini) of specific elastin-derived peptide sequences. Although the primary tested...
3 claims
|
|
Elastin-Derived Peptides in the Central Nervous System Friend or Foe2021
This is a review focused on Elastin-Derived Peptides (EDPs), explicitly naming key sequences like VGVAPG and Elastin-Like Polypeptides (ELPs). While the context is the Central Nervous System (CNS),...
3 claims
|
|
Elastin-Derived VGVAPG Fragment Decorated Cell-Penetrating Peptide with Improved Gene Delivery Effic2023
The document investigates a peptide (RALA-E) engineered using the critical elastin-derived fragment VGVAPG (Table 1), providing the full sequence and modification (attachment to RALA). Although the...
3 claims
|
|
Elastin-Like Polypeptide Nanoparticles as Carriers for Anti-EGFR Peptide TherapeuticsThe document focuses heavily on Elastin-Like Polypeptides (ELPs) derived from elastin sequences (e.g., VPGVG repeats) and their construction/characterization. Although the primary therapeutic goal is...
3 claims
|
|
Elastin-Like Recombinamer Hydrogels for Improved Skeletal Muscle Healing Through Modulation of Macro2020 · Frontiers in Bioengineering
The document details the engineering and characterization of Elastin-Like Recombinamers (ELRs), which are synthetic peptides based on the VPGXG motif found in natural elastin. It reports specific...
3 claims
|
|
Elastin-derived peptides (EDPs) as a potential pro-malignancy factor in human leukemia cell lines.2024
The research goal requires capturing data on specific peptide sequences (VGVAPG and VVGPGA), their outcomes (positive/negative/inconclusive), and full methodological details (sequence, cell type,...
3 claims
|
|
Elastin-derived peptides are new regulators of thrombosis.4432
The document identifies and characterizes the activity of key elastin-derived peptides (EDP), specifically the canonical sequence VGVAPG, providing its concentration, cell type (human/mouse), and...
2 claims
|
|
Elastin-like polypeptides as a promising family of genetically-engineered protein based polymers.2014
The document provides detailed information on the specific peptide sequences that constitute Elastin-Like Polypeptides (ELP), such as the repeating pentapeptide Val–Pro–Gly–Xaa–Gly ([VPGXG]n), and...
2 claims
|
|
Elastin Based ConstructsThe document provides critical biological context, identifies key cell types (SMCs, fibroblasts), and explicitly mentions the VGVAPG peptide sequence, a major active site often utilized or modified...
3 claims
|
|
Elastin Structure, Synthesis, Regulatory Mechanism and Relationship With Cardiovascular Diseases2021 · Frontiers in Cell
The document is a review covering Elastin Synthesis and Regulatory Mechanisms. Reviews on regulatory mechanisms often summarize or cite experimental studies detailing specific molecules (including...
3 claims
|
|
Elastin in the Liver2016 · Frontiers in Physiology
This is a review focused on elastin biochemistry and physiology, explicitly mentioning tropoelastin structure, repeating motifs (e.g., GVGVAP), and the biological activity of elastin peptides...
3 claims
|
|
Elastin peptides in aging and pathological conditionsThis is a review focused on the nature and role of Elastin Peptides (EPs) and their receptors in tissue homeostasis and pathology. Studies detailing EPs necessarily involve specific sequence...
2 claims
|
|
Elastin peptides regulate HT-1080 fibrosarcoma cell migration and invasion through an Hsp90-dependenThe document tests specific peptide sequences (VGVAPG, AGVPGLGVG, GRKRK) derived from elastin at defined concentrations (e.g., 200 µg/ml) and reports their activity classification (positive or no...
3 claims
|
|
Elastin‑derived peptides are involved in the processes of human temporomandibular disorder by induciThe document investigates the bioactivity of elastin-derived peptides (EDPs) on human synovial cells, specifically mentioning the key sequence VGVAPG as the potentially active hexapeptide that binds...
3 claims
|
|
Elucidating the Pathogenesis of Pre-eclampsia Using In Vitro Models of Spiral Uterine Artery Remodel2017
The document explicitly identifies an elastin-derived peptide (matrikine), VGVAPG, and reports its quantitative functional outcome (increased invasion) on SGHPL-4 trophoblast cells using a transwell...
3 claims
|
|
Engineered Nanotechnology An Effective Therapeutic Platform for the Chronic Cutaneous Wound2022
The document is a review on engineered nanotechnology for chronic wound healing and tissue regeneration. Wound healing involves the restoration of the extracellular matrix (ECM), including elastin...
1 claim
|
|
Epidermal Growth Factor in Aesthetics and Regenerative Medicine Systematic Review.Journal of Cutaneous and Aesthetic Surgery
The document, a systematic review on Epidermal Growth Factor (EGF), discusses a specific polypeptide sequence (EGF) used for skin restructuring. It explicitly states that its mechanism involves...
3 claims
|
|
Erythromycin Prevents Elastin Peptide-Induced Emphysema and Modulates CD4+T Cell Responses in MiceJournal of Chronic Obstructive Pulmonary Disease
The research goal requires specific peptide sequences tested in elastin research, including inactive controls. This document explicitly identifies and uses a known elastin-derived peptide sequence,...
2 claims
|
|
Evaluation of Fluorine-18-Labeled α1(I)-N-Telopeptide Analogs as Substrate-Based Radiotracers for PE2018 · Frontiers in Chemistry
The document investigates peptide sequences (telopeptide analogs) and modifications (F-18 labeling, LYS substitution with ORN/NLE) as substrates for Lysyl Oxidase (LOX). LOX is the critical enzyme...
3 claims
|
|
Exploring Greek actinobacterial biodiversity for the discovery of bioactive metabolites with skin anFrontiers in Microbiology
The document investigates anti-aging compounds and specifically identifies and tests defined peptide sequences (cyclic dipeptides: Cyclo (L-proline-L-tyrosine) and Cyclo (Pro-Phe)) for activity...
3 claims
|
|
Exploring the Impact of Hydrolyzed Collagen Oral Supplementation on Skin Rejuvenation A Systematic R2017
The document reviews the effects of Hydrolyzed Collagen (HC) oral supplementation on skin elasticity. HC is a mixture of peptides/dipeptides (e.g., containing proline and glycine) derived from...
3 claims
|
|
Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration A Comprehensive Review2016 · Journal of Medical Sciences
The document is a review focusing on bioactive tripeptides and their role in skin regeneration and extracellular matrix (ECM) remodeling. The abstract explicitly states that GHK-based formulations...
2 claims
|
|
Extracellular EDPs at high concentrations participate in neuronal cytoskeleton assembly and AD etiolThe document explicitly identifies specific Elastin-Derived Peptide sequences, (VGVAPG)₃ and the inactive control (VVGPGA)₃, along with quantitative results (CCK-8 cell viability) across a wide range...
3 claims
|
|
Extracellular Matrix Molecules Facilitating Vascular Biointegration2012 · Funct. Biomater.
This review focuses on extracellular matrix (ECM) components like tropoelastin and elastin in the context of biomaterials and vascular biointegration. It discusses the use of peptides derived from...
3 claims
|
|
Extracellular matrix derived peptides and mesenchymal stem cell motilityThe document investigates bioactive peptides (matrikines/matricryptins) derived from extracellular matrices, which is the chemical class of interest (elastin peptides are matrikines). It uses mass...
3 claims
|
|
Extracellular matrix proteases contribute to progression of pelvic organ prolapse in mice and humansJournal of Clinical Investigation
The document investigates the molecular role of Fibulin-5 in elastic fiber assembly (elastogenesis) and maintenance, which is the core domain of the research goal. Specifically, it characterizes the...
3 claims
|
|
Fibrillar Self-Assembly of a Chimeric Elastin-Resilin Inspired Engineered Polypeptide.2019
The document investigates a well-defined, engineered chimeric polypeptide sequence derived from elastin and resilin, and includes preliminary biological testing (cytotoxicity) on human fetal foreskin...
3 claims
|
|
Fibrillin-1 and elastin fragmentation in the pathogenesis of thoracic aortic aneurysm in Marfan syndProf. Dr.
The document investigates the role of Fibrillin-1 fragments, specifically those containing the GxxPG consensus sequence, in aortic pathology related to elastin breakdown (Marfan syndrome). The...
3 claims
|
|
Fibrous Scaffolds From Elastin-Based Materials2021 · Frontiers in Bioengineering
This review focuses on Elastin-Like Recombinamers (ELRs) and synthetic elastin-based peptides/proteins. The discussion of ELRs requires defining specific repeating peptide sequences (e.g., VPGVG,...
2 claims
|
|
Fish Collagen Peptide (NaticolⓇ) Protects the Skin from Dryness, Wrinkle Formation, and Melanogenesi2007 · Prev. Nutr.
The document investigates the anti-wrinkle activity of a fish collagen peptide hydrolysate (NaticolⓇ) in human fibroblasts (Hs27 cells) and provides the quantitative level of a specific internal...
2 claims
|
|
Food Peptides for the Nutricosmetic Industry.2023
This document is a review summarizing bioactive peptides (biopeptides) for the nutricosmetic/anti-aging industry. The introduction explicitly mentions 'signal peptides' that 'stimulate matrix protein...
2 claims
|
|
Framing Heartaches The Cardiac ECM and the Effects of Age2023 · Age. Int.
The document is a detailed review of the cardiac Extracellular Matrix (ECM) composition, structure, and remodeling, which includes components essential for elasticity (elastin, collagen). Although...
1 claim
|
|
Free and encapsulated stem cells for skin regenerationThis is a review on skin regeneration using tissue engineering and stem cells, focusing on restoring the dermal layer which relies heavily on elastin. Reviews in this domain often summarize the use...
2 claims
|
|
Functional Vascular Tissue Engineering Inspired by Matricellular Proteins2019 · Frontiers in Cardiovascular Medicine
The research goal seeks peptide sequences that stimulate elastin activity and their quantitative outcomes. This document is a mini-review focused on 'Functional Vascular Tissue Engineering Inspired...
3 claims
|
|
Ginseng glycoprotein and ginsenoside facilitate anti UV damage effects in diabetic rats.2022 · Frontiers in Pharmacology
The document investigates a ginseng glycoprotein (a complex polypeptide) in an animal model of skin damage. The introduction explicitly notes that UV rays 'destroy the skin’s collagen and elastin...
3 claims
|
|
Glycolytic Reprogramming in Silica-Induced Lung Macrophages and Silicosis Reversed by Ac-SDKP Treatm2021 · Treatment.
Int.
The document investigates the N-acetylated peptide, Ac-SDKP, in a lung fibrosis model (silicosis). The introduction explicitly links this disease model to the downregulation of elastin levels....
2 claims
|
|
Heparan sulfates facilitate harmless amyloidogenic fibril formation interacting with elastin-like pe2018
The document investigates synthetic Elastin-Like Peptides (ELPs) with defined sequences ((VGGVG)n, (LGGVG)n), reporting on their structural properties (aggregation kinetics/fibril formation) and...
3 claims
|
|
Histological Changes Associated with Extracellular Matrix-Remodeling Topical Therapy2017
The document reports positive in vivo (human subjects) results for elastin-stimulating activity (elastogenesis) using a proprietary blend of peptides (TriHex Technology™). It specifically mentions...
1 claim
|
|
Hold on or Cut Integrin- and MMP-Mediated Cell–Matrix Interactions in the Tumor Microenvironment2020 · Microenvironment. Int.
The document is a review focusing on the Extracellular Matrix (ECM) and its remodeling, explicitly mentioning elastin and 'elastin degradation peptides (EDPs)' (matrikines). These peptides are often...
2 claims
|
|
Hydrogel scaffolds as in vitro models to study fibroblast activation in wound healing and diseaseBiomater. Sci.
The document is a mini-review detailing in vitro hydrogel models used to study fibroblast function, activation, and matrix synthesis/remodeling (ECM production). It explicitly mentions the use of...
3 claims
|
|
Hydrolyzed Collagen-Sources and Applications.2019
The document reviews Hydrolyzed Collagen (HC), which is composed of low molecular weight peptides (3–6 KDa). HC peptides are a major class of compounds studied for skin elasticity and extracellular...
2 claims
|
|
Identification and Evaluation of New Potential Inhibitors of Human Neuraminidase 1 Extracted from i2021
The document focuses on inhibitors of Human Neuraminidase 1 (NEU-1). NEU-1 is explicitly linked to elastin metabolism as it is the catalytic subunit of the Elastin Receptor Complex (ERC), which binds...
1 claim
|
|
Identification and Characterization of Novel Matrix-Derived Bioactive Peptides A Role for CollagenasThe document identifies and characterizes novel chemically-synthesized bioactive peptides derived from the extracellular matrix (ECM) of human dermal cells (collagen, fibronectin, etc.). It tests...
3 claims
|
|
Identification of CD36 as a new interaction partner of membrane NEU1 potential implication in the pr2018
The document investigates Elastin-Derived Peptides (EDP) and their interaction with the Elastin Receptor Complex (ERC). It explicitly provides the sequence of the inhibitory peptide V14...
3 claims
|
|
Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease MicroenvironmentFrontiers in Immunology
The document reviews the Extracellular Matrix (ECM), which includes elastin, and focuses heavily on 'immune-active peptides and domains' derived from ECM remodeling, known as DAMPs (Damage-Associated...
3 claims
|
|
Impact of Elastin-Derived Peptide VGVAPG on Matrix Metalloprotease-2 and -9 and the Tissue Inhibitor2018
The document directly investigates the impact of a key elastin-derived peptide sequence (VGVAPG) on matrix remodeling enzymes (MMPs and TIMPs) in a defined cell type (mouse cortical glial cells)...
3 claims
|
|
Impact of elastin-derived VGVAPG peptide on bidirectional interaction between peroxisome proliferato2018
The document provides precise quantitative data (sequence: VGVAPG, length: 6, cell type: mouse astrocytes, concentrations: 50 nM to 50 µM) regarding the biological activity of a key elastin-derived...
3 claims
|
|
Important roles of dietary taurine, creatine, carnosine, anserine and 4-hydroxyproline in human nutr2020 · Frontiers in Agricultural
The document is a review that discusses specific dipeptides (Carnosine, Anserine) and amino acid derivatives (4-hydroxyproline) and explicitly links them to improving 'skin and bone health.' Although...
3 claims
|
|
In Vitro Comparative Study of Calcium Hydroxyapatite (Stiim) Conventional Saline Dilution Versus PolThe document investigates the biostimulatory effects of a poly-micronutrient solution containing several specific named bioactive peptides (Matrixyl, Syn-Coll, Syn-Hycan, Syn-TC, Syn-Tacks, Syn-UP,...
3 claims
|
|
In Vitro and In Silico Wound-Healing Activity of Two Cationic Peptides Derived from Cecropin D in &l2025
The document tests specific peptide sequences (cationic peptides derived from Cecropin D) on fibroblasts (Detroit 551 cells) for wound-healing and tissue regeneration activity, providing quantitative...
3 claims
|
|
In vitro and in vivo Evaluation on the Safety and Efficacy of a Brand-New Intracutaneous Filler withThe document investigates the in vitro efficacy of a formula containing specific dipeptide sequences (AlaPro, ProGly, GlyPro) and key amino acids (Valine, Glycine, Proline) for stimulating...
3 claims
|
|
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes.The document explicitly tests and provides quantitative outcomes for a specific named peptide sequence, Thymosin β4 (Tβ4), described as a 'fibroblast activating peptide.' While the main outcome...
2 claims
|
|
Inclusion of Cross-Linked Elastin in Gelatin PEG Hydrogels Favourably Influences Fibroblast Phenotyp2020
The document provides quantitative results (6-fold increase in elastin expression at day 9) and activity classification regarding elastin synthesis (elastin-stimulating activity) by Normal Human...
3 claims
|
|
Induction of MMP-9 release from human dermal fibroblasts by thrombin involvement of JAK STAT3 signal2007
The document tests two explicit, short, modified peptide sequences (SFLLR-NH2, RLLFS-NH2) on human dermal fibroblasts (HDFs) and provides quantitative data on their ability to induce MMP-9 release....
3 claims
|
|
Influence de l'élastolyse dans la physiopathologie gingivaleThe document provides explicit peptide sequences (VGVAPG, VGVAPG3, kappa-elastin), specific concentrations (100 µg/ml, 200 µg/ml), cell type (human gingival fibroblasts), and quantitative results...
3 claims
|
|
Infraorbital Dark Circles A Review of the Pathogenesis, Evaluation and TreatmentJournal of Cutaneous and Aesthetic Surgery
The document is a review on the pathogenesis and treatment of periorbital aging, which explicitly mentions 'loss of elasticity and turgor as a result of collagen and/or elastin loss.' The document...
2 claims
|
|
Injectable Gelatin–Palmitoyl–GDPH Hydrogels as Bioinks for Future Cutaneous Regeneration Physicochem2024
The document investigates a modified peptide sequence, Palmitoyl–GDPH (palmitic acid–glycine–aspartic acid–proline–histidine), used in a context (cutaneous regeneration, Human Dermal Fibroblasts)...
3 claims
|
|
Innovative Approaches to an Eco-Friendly Cosmetic Industry A Review of Sustainable Ingredients2024
This document is a review of sustainable cosmetic ingredients. The goal focuses on peptide sequences stimulating elastin. Cosmetic ingredients frequently include anti-aging peptides targeting the...
1 claim
|
|
Insights into preclinical models of calcific aortic valve disease and their translational potential2025 · Front. Cardiovasc. Med.
The document is a review of preclinical models and mechanisms for Calciîc Aortic Valve Disease (CAVD). CAVD involves significant extracellular matrix (ECM) remodeling, and the document explicitly...
1 claim
|
|
Insights into Bioactive Peptides in Cosmetics2023
This document is a review article on bioactive peptides in cosmetics, which explicitly discusses the classification and mechanisms of action of peptides. It specifically addresses 'elastin'...
2 claims
|
|
Interaction Between Aging-Related Elastin-Derived Peptide (VGVAPG) and Sirtuin 2 and its Impact on F2024
The document provides sequence (VGVAPG), cell type (SH-SY5Y), concentration/methodology (implied by M&M), and detailed quantitative outcomes (e.g., 52.69% decrease in ROS) for a known elastin-derived...
2 claims
|
|
Interaction between the antagonist of the N-methyl-D-aspartate receptor (NMDAR) and elastin-derivedThe document investigates the biological activity of the key elastin-derived peptide VGVAPG (sequence and concentrations provided) and links its mechanism (AhR expression) to extracellular matrix...
3 claims
|
|
Iontophoretic Delivery of Hyaluronic Acid Nanogel-Loaded Fermented Rice Extract Mitigates Skin GlycaThe document investigates mitigating skin glycation, a process known to damage and degrade elastin fibers, resulting in loss of elasticity. Although it focuses on an extract (Fermented Rice Extract)...
3 claims
|
|
Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitisJournal of Clinical Investigation
The document investigates the Laminin Receptor (LR), which it explicitly states binds basement membrane components, including elastin. It then uses defined synthetic LR peptides (263–282 and 161–182,...
2 claims
|
|
Liposome Encapsulation of the Palmitoyl–KTTKS Peptide Structural and Functional Characterization2024
The document studies the modified peptide pal-KTTKS and provides structural details (sequence, modification) and quantitative functional outcomes (concentration, cell type, assay method, results)...
3 claims
|
|
Liposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Application2023
The document investigates the copper tripeptide GHK-Cu (Glycyl-L-histidyl-L-lysine complexed with copper) which is explicitly noted as stimulating elastin synthesis in the introduction. Crucially,...
3 claims
|
|
Longevity-Promoting Pathways and Transcription Factors Respond to and Control Extracellular Matrix DThe document is a review focusing extensively on Extracellular Matrix (ECM) remodeling, aging, and longevity pathways (mTOR, FOXO, Nrf2). While it focuses on genetic and signaling regulation rather...
1 claim
|
|
Lysyl Oxidase Enhances the Deposition of Tropoelastin through the Catalysis of Tropoelastin Molecule2017 · Biol. Pharm. Bull.
The document investigates the mechanism of tropoelastin deposition and assembly in relevant human dermal fibroblast cell lines (NHDF-neo, NHDF-Ad), mentioning specific endogenous elastin repeat...
3 claims
|
|
Macrofungal Extracts as a Source of Bioactive Compounds for Cosmetical Anti-Aging Therapy A Comprehe2024
The review focuses on bioactive compounds from macrofungal extracts used for anti-aging therapy. The abstract explicitly states these compounds include 'polysaccharide peptides' and work by...
1 claim
|
|
Macrophage-extracellular matrix interactions Perspectives for tissue engineered heart valve remodeli2022 · Frontiers in Cardiovascular Medicine
The document is a review focusing on extracellular matrix (ECM) remodeling and tissue engineering, specifically mentioning the critical role of elastin fibers in heart valve structure. The scope...
3 claims
|
|
Marine Macroalgae in Topical Formulations Bioactive Compounds, Variability, Analytical Challenges an2025
The document is a review focusing on macroalgae-derived bioactive compounds, explicitly mentioning 'peptides' and their documented 'anti-aging activity' and 'skin benefits' in topical formulations....
2 claims
|
|
Matrikines are key regulators in modulating the amplitude of lung inflammation in acute pulmonary in2015
The document investigates bioactive matrix fragments (matrikines) derived from ECM degradation, specifically characterizing the tripeptide sequence PGP (Proline–Glycine–Proline). Although the primary...
3 claims
|
|
Matrix- and plasma-derived peptides promote tissue-specific injury responses and wound healing in di2016
The document investigates novel, short, protease-resistant peptides (Comb1 and UN3) derived from extracellular matrix fragments that promote dermal matrix remodeling, including the upregulation of...
3 claims
|
|
Matrix Metalloproteinases Inhibitors in Cancer Treatment An Updated Review (2013-2023).2023
The document reviews Matrix Metalloproteinases (MMPs), including metalloelastase (MMP-12, MMP-2, MMP-9, MMP-13) which degrade elastin. Although the focus is on MMP inhibitors (MMPi) for cancer, the...
2 claims
|
|
Matrix Metalloproteinases in Chronic Obstructive Pulmonary Disease2023 · Disease. Int.
The document reviews Matrix Metalloproteinases (MMPs), which are the primary agents of elastin degradation. It discusses MMPs as therapeutic targets. If the review includes data on peptide sequences...
1 claim
|
|
Mechanisms on How Matricellular Microenvironments Sustain Idiopathic Pulmonary Fibrosis2025 · Fibrosis.
Int.
The document is a review focusing on the mechanisms of extracellular matrix (ECM) remodeling, fibroproliferation, and matrix synthesis (by fibroblasts/myofibroblasts) in idiopathic pulmonary fibrosis...
3 claims
|
|
Mesenchymal Stromal Cells Combined With Elastin-Like Recombinamers Increase Angiogenesis In Vivo AftThe document uses and details specific Elastin-Like Recombinamers (ELRs) containing highly relevant core peptide sequences derived from elastin structure (VPGXG repeats) and bioactive domains (RGD,...
3 claims
|
|
Microbial Fermentation of Industrial Rice-Starch Byproduct as Valuable Source of Peptide Fractions w2020
The document investigates peptide fractions derived from microbial fermentation for 'health-related activity' and 'anti-aging effects.' Crucially, the Materials section explicitly lists the use of...
3 claims
|
|
Microfibril-associated glycoprotein 4 forms octamers that mediate interactions with elastogenic prot2024
The document investigates the structure and function of MFAP4, a glycoprotein critical for elastogenesis, and reports on its direct interactions with tropoelastin and fibrillin-1, including its role...
3 claims
|
|
Microneedles-A new paradigm in transdermal delivery of therapeutic agentsThe document reviews microneedles for transdermal drug delivery, explicitly mentioning the delivery of 'peptides' and discussing mechanisms of 'dermal regeneration' and 'neocollagenesis' (tissue...
2 claims
|
|
Modification Strategies for Ionic Complementary Self-Assembling Peptides Taking RADA16-I as an Examp2022
This review summarizes modification strategies for self-assembling peptides (like RADA16-I) using 'active motifs derived from the active domain of the extracellular matrix' for use in regenerative...
1 claim
|
|
Modification of Alginates to Modulate Their Physic-Chemical Properties and Obtain Biomaterials with2021
This document is a review focusing on the functionalization of alginates using natural and synthetic peptides to obtain biomaterials with diverse biological activity for regenerative medicine...
3 claims
|
|
Modular and orthogonal synthesis of hybrid polymers and networks.4545
This is a review on the modular synthesis of hybrid biomaterials (including peptides/proteins) for 3D cell culture and tissue engineering, which is the adjacent domain where peptides are screened for...
2 claims
|
|
Molecular Mechanisms of Dermal Aging and Antiaging Approaches.2019
This is a comprehensive review on dermal aging and antiaging approaches. Antiaging approaches, particularly topical treatments discussed in such reviews, commonly include specific peptides designed...
2 claims
|
|
Molecular Research on Oral Diseases and Related Biomaterials A Journey from Oral Cell Models to Adva2022 · Perspectives. Int.
This is a review focused on regenerative perspectives and biomaterials for oral tissues. It explicitly mentions 'antimicrobial peptides' and discusses tissue remodeling and mechanotransduction. Given...
3 claims
|
|
Molekulare und klinische Untersuchungen beim Marfan-Syndrom und verwandten ErkrankungenProf. Dr.
The document focuses on the molecular pathology of Marfan Syndrome (Fibrillin-1 mutations), which is fundamentally a disease of elastic fibers and their scaffolding. Section 2.3/3.3 specifically...
2 claims
|
|
Multifunctional biomaterial platforms for blocking the fibrosis process and promoting cellular resto2022 · Frontiers in Bioengineering
This document reviews biomaterial platforms for myocardial fibrosis therapy, which focuses on regulating and restoring the extracellular matrix (ECM). Given that elastin is a critical ECM component...
3 claims
|
|
Nanomaterials in Wound Healing and Infection Control.2021
The document is a review on nanomaterials in wound healing. Wound healing inherently involves the proliferation phase where 'fibroblasts proliferate and elastin is produced' (Section 2.2)....
1 claim
|
|
Natural and Genetically Engineered Proteins for Tissue Engineering.2011
Review covers natural and genetically engineered proteins and peptides (including self-assembling peptides and bioactive domains) for tissue engineering. Elastin-like polypeptides (ELPs) and peptides...
2 claims
|
|
Natural biopolymer-based hydrogels as designer matrices for organoid culturesThe document, a review on hydrogels for organoid culture, explicitly categorizes and discusses peptides as natural biopolymers used for designing artificial extracellular matrices (ECM). Although it...
3 claims
|
|
Non-invasive in vivo imaging of changes in Collagen III turnover in myocardial fibrosis.The research goal explicitly requests capturing quantitative results for peptide sequences tested against elastin activity, including inactive controls. Supplementary Figure 2 provides quantitative...
2 claims
|
|
Nonprescription Topical Treatments for Skin RejuvenationThe document reviews nonprescription treatments and explicitly names a specific, modified peptide complex, GHK-Cu (glycyl-L-histidyl-L-lysine-Cu2+), used for enhancing the dermal layer and augmenting...
3 claims
|
|
Novel Hydrogel-forming elastin-like recombinamers for biomedical applicationsThe document is a doctoral thesis focused on Elastin-Like Recombinamers (ELRs), which are synthetic protein polymers based on defined elastin peptide sequences. The index indicates detailed reporting...
3 claims
|
|
Oligomeric hyaluronic acid-modified liposomes effectively improved skin permeability and anti-ageingThe document explicitly uses 'acetyl hexapeptide-8' as a positive control in a study measuring the upregulation of the elastin gene in zebrafish. The research goal requires capturing known peptide...
2 claims
|
|
Optimization of extraction and purification of the M protein fused GCN4pII motif and elastin like po2024 · Journal of Biotechnology
The document utilizes and defines an Elastin-Like Polypeptide (ELP) consisting of repeating VPGXG pentapeptides derived from elastin. Although the primary research focus is vaccine production and...
3 claims
|
|
Oral Collagen Peptides and Vulvovaginal Radiofrequency Therapy for Genitourinary Syndrome of Menopau2025 · Clin. Med.
The document investigates specific 'bioactive collagen peptides (BCPs®)' administered orally, noting their established mechanism of stimulating fibroblast activity and promoting extracellular matrix...
3 claims
|
|
Oral Intake of Chicken Bone Collagen Peptides Anti-Skin Aging in Mice by Regulating Collagen Degrada2022
The document studies the anti-aging effects of a mixture of small collagen peptides (<3000 Da) derived from chicken bone, focusing on regulating the skin extracellular matrix (ECM) components like...
3 claims
|
|
PKCδ as a regulator for TGFβ1-induced α-SMA production in a murine nonalcoholic steatohepatitis mode2013 · PLOS ONE
The document investigates a peptide inhibitor (dV1-1, sequence C-SFNSYELGSL) conjugated to a carrier peptide (TAT) used in a murine model of Nonalcoholic Steatohepatitis (NASH), a tissue...
2 claims
|
|
Peptide-Based Functional Biomaterials for Soft-Tissue Repair2019 · Frontiers in Bioengineering
The document is a review focused on 'Peptide-Based Functional Biomaterials for Soft-Tissue Repair.' It explicitly mentions the need to mimic native ECM components like 'collagen and elastin' and...
3 claims
|
|
Peptides Emerging Candidates for the Prevention and Treatment of Skin Senescence A Review2025
This is a review article on cosmetic and anti-aging peptides used for skin senescence, which involves maintaining elasticity and structure. The document explicitly mentions peptides that 'Promote...
3 claims
|
|
Peptides and Their Mechanisms of Action in the Skin2024 · Skin.
Appl. Sci.
The document is an editorial review of bioactive peptides used in skin care. It explicitly names several modified peptides (e.g., Pal-KTTKS, Ac–Asp–Val–Lys–Tyr–OH) and reports their activity...
3 claims
|
|
Pharmacomodulation of Broad Spectrum Matrix Metalloproteinase Inhibitors Towards Regulation of GelatThe document focuses on Matrix Metalloproteinases (MMPs), specifically gelatinases (MMP-2 and MMP-9), which are classified as elastases responsible for degrading elastic tissues. Research into the...
3 claims
|
|
Phototherapy to Facilitate Wound Healing Following Pacemaker Infection A Promising Tool to Improve OThe document discusses the mechanism of a phototherapy patch, which involves increasing levels of the peptide glycyl-L-histidyl-L-lysine (GHK). It explicitly states that this peptide is known to...
2 claims
|
|
Phytochemical and Potential Properties of Seaweeds and Their Recent Applications A Review.2022 · Review. Mar.
The document is a review focused on bioactive compounds and applications of seaweeds, explicitly mentioning their use in cosmeceuticals and for treating 'aging' and 'matrix metalloproteinase...
2 claims
|
|
Plant and Microalgae Derived Peptides Are Advantageously Employed as Bioactive Compounds in Cosmetic2019 · Frontiers in Plant Science
This review discusses bioactive peptides used in cosmetics, specifically providing details on several sequences (e.g., GHK, GEKG, KTTKS, RGD) and their modifications (copper complexation,...
2 claims
|
|
Potential Cosmetic Active Ingredients Derived from Marine By-Products2022 · Products. Mar.
The document is a review on marine-derived cosmetic active ingredients, specifically focusing on hydrolyzed collagen/peptides used for anti-wrinkle/anti-aging effects. Elastin stimulation is a key...
3 claims
|
|
Preventive and Therapeutic Interventions in Solar Elastosis and Photoaging A Comprehensive Systemati2025
This systematic review analyzes preventive and therapeutic interventions for solar elastosis and photoaging, which are characterized by dysfunctional dermal elastic matrix. The review explicitly...
2 claims
|
|
Proceedings of the 35th European Peptide SymposiumJournal of Peptide Science and the
The document is the proceedings of the European Peptide Symposium, which covers the chemistry, biochemistry, biology, and pharmacology of peptides. It includes 'Articles' and numerous presentations...
3 claims
|
|
Proceedings of the XXXVII National Meeting of the Italian Society for the Study of Connective Tissue1979 · Journal of Histochemistry was founded
The document is the proceedings/abstract volume for the 'XXXVII MEETING OF THE ITALIAN SOCIETY FOR THE STUDY OF CONNECTIVE TISSUES (SISC 2017)'. Elastin is a crucial component of connective tissues...
2 claims
|
|
Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development.The document investigates the proteolysis of Fibrillin-1 and Fibrillin-2 microfibrils, which are essential components for elastic fiber assembly. The study explicitly identifies specific cleavage...
3 claims
|
|
Pulmonary Emphysema Current Understanding of Disease Pathogenesis and Therapeutic Approaches2025
The document is a review covering the pathogenesis of pulmonary emphysema, which is characterized by the destruction of elastin. It explicitly discusses 'Exploratory Therapeutic Approaches' aimed at...
1 claim
|
|
RECENT ADVANCES IN ELASTIN-BASED BIOMATERIALSThe document is a review focusing on elastin-derived peptides and elastin-like polypeptides (ELPs), discussing their structure (e.g., VPGXG repeats, GVGVP, GGVP, GVGVAP), physicochemical properties,...
2 claims
|
|
RNA Sequencing and Related Differential Gene Expression Analysis in a Mouse Model of Emphysema InducThe document explicitly reports the sequence (VGVAPG) of an elastin peptide, its concentration (100 µg/mL), and its observed biological activity (induction of emphysema/inflammation) in an animal...
2 claims
|
|
Recent Advances in Microneedling-Assisted Cosmetic Applications2024
This is a review paper on cosmetic applications that explicitly mentions the use of peptides as cosmetic agents delivered via microneedling, and states that microneedling stimulates collagen and...
2 claims
|
|
Red-light induced aggregation of phytochrome 1 decorated e2 protein nanocageThe document utilizes and characterizes an Elastin-Like Polypeptide (ELP80) sequence as part of a fusion protein (Cph1-ELP80-SpyCatcher). While the study focuses on affinity precipitation and...
3 claims
|
|
Regulation of Uterine Spiral Artery Remodeling a Review.2020
The document explicitly identifies and reports the activity of the specific elastin-derived peptide (matrikine) sequence VGVAPG, stating that it increased trophoblast migratory capacity in vitro....
2 claims
|
|
Research Progress in Skin Aging, Metabolism, and Related Products2023 · Products.
Int.
This is a review article on skin aging, metabolism (specifically protein metabolism), and related products. The abstract and introduction explicitly mention that fibroblasts synthesize collagen and...
2 claims
|
|
Research Progress on Bioactive Factors against Skin Aging2024 · Aging. Int.
The document is a comprehensive review on bioactive factors, specifically including peptides (polypeptides), utilized for anti-skin aging. Research on anti-aging peptides frequently covers...
3 claims
|
|
Research Progress on New Functions of Animal and Plant Proteins2024
This review discusses the biological activity of peptides derived from animal and plant proteins, specifically addressing anti-skin photoaging, which involves the extracellular matrix (ECM)...
1 claim
|
|
RiboScreen sup TM sup Technology Delivers a Ribosomal Target and a Small-Molecule Ligand for Ribosom2024 · Elastin. Int.
The document investigates boosting tropoelastin production (elastin-stimulating activity), providing quantitative results and cell culture context, which are key requirements of the research goal....
3 claims
|
|
Revisited and innovative perspectives of oral ulcer from biological specificity to local treatmentThe document reviews the mechanisms of mucosa-inspired scarless healing, which necessitates detailed discussion of extracellular matrix (ECM) components, including elastin regulation, compared to...
1 claim
|
|
Role of peptide–cell surface interactions in cosmetic peptide application2023
The document investigates specific cosmetic peptide sequences (GHK, RGD-GHK, sOtx2-GHK) for their anti-aging activity in skin models. The research goal requires identifying peptides with...
3 claims
|
|
Selected Medicinal Herbs and Functional Peptides for Protection against Photoaging of the Skin2019 · Journal of Cosmetics
The document is a mini-review summarizing functional peptides used for protection against photoaging. Since photoaging involves the destruction of dermal elastic fibers, it is highly probable that...
1 claim
|
|
Selenized Chickpea Sprouts Hydrolysates as a Potential Anti-Aging Ingredient.2023
The document investigates anti-aging bioactive peptides derived from food sources and explicitly evaluates their inhibitory effects on elastase and collagenase. While it reports elastase inhibition...
3 claims
|
|
Skin irritation and potential antioxidant, anti-collagenase, and anti-elastase activities of edible2021
The document investigates anti-elastase activity of protein-rich insect extracts, which is an adjacent domain to elastin-stimulating activity (elastogenesis). Although specific peptide sequences are...
2 claims
|
|
Skin manifestations in diabetes—what is newFrontiers in Medicine
The document is a review on diabetic skin manifestations and current treatments, mentioning 'specialised bioactive dressings' and 'anti-fibrotic therapies.' Pathologies like diabetic thick skin and...
1 claim
|
|
Specific role of N-methyl-D-aspartate (NMDA) receptor in elastin-derived VGVAPG peptide-dependent ca2019
The document explicitly tests the elastin-derived peptide VGVAPG (10 nM) and the control sequence VVGPGA (a required data point for model training, as per the research goal). It provides specific...
3 claims
|
|
Spent Yeast Waste Streams as a Sustainable Source of Bioactive Peptides for Skin Applications2023 · Applications. Int.
The document explicitly evaluates the capacity of various peptide fractions (separated by molecular weight/length criteria, e.g., >1 kDa) to modulate the production of elastin in human skin cells...
2 claims
|
|
State-of-the-Art of Eggshell Waste in Materials Science Recent Advances in Catalysis, Pharmaceutical2021 · Frontiers in Bioengineering
The document reviews the use of the proteinaceous Eggshell Membrane (ESM) in biomedical applications, reparative medicine, and tissue engineering. ESM contains specific proteins (e.g., high in...
2 claims
|
|
Structural and functional analysis of a homotrimeric collagen peptide.The research goal seeks peptide sequences tested for elastin-stimulating activity. This document investigates a synthesized homotrimeric collagen peptide (based on Glycine, Proline, and...
2 claims
|
|
Structural characterization and in vivo pro-tumor properties of a highly conserved matrikineThe document investigates and provides structural and functional data for specific elastin-derived peptides (EDPs): AGVPGLGVG (AG-9) and VGVAPG (VG-6). The research goal explicitly requires capturing...
3 claims
|
|
Study on the Skincare Effects of Red Rice Fermented by i Aspergillus oryzae i In Vitro.2024
The document investigates the anti-aging effects of a fermentation product (RRFA) which is stated to contain peptides (0.22 wt%). Crucially, it directly measures and quantifies the...
3 claims
|
|
Study on the Effect of Bee Venom and Its Main Component Melittin in Delaying Skin Aging in Mice.2025 · Mice. Int.
The document investigates the peptide Melittin (MLT) for its anti-aging effects, providing quantitative data (doses of 0.05 and 0.5 mg·kg⁻¹, increased collagen content, hydroxyproline levels, and...
3 claims
|
|
Synergistic Antibacterial Effect of Mucus Fraction from <i>Cornu aspersum< i> and Cirpof2025
The document investigates a protein/peptide fraction from snail mucus for its wound-healing activity on normal human fibroblasts and keratinocytes. Although the primary focus is antibacterial...
3 claims
|
|
Synergistic effect of collagen peptide and elastin peptide derived from salmon on promoting hyaluron2009
The document investigates a salmon-derived Elastin Peptide (EP, Mw 1,600) on human dermal fibroblasts (SF-TY), providing quantitative outcomes (hyaluronic acid production and cell proliferation) and...
2 claims
|
|
Synthetic and Natural Agents Targeting Advanced Glycation End-Products for Skin Anti-Aging A Compreh2025
The document reviews anti-aging agents focused on mitigating Advanced Glycation End-products (AGEs), which cause cross-linking and degradation of dermal matrix proteins (including elastin)....
3 claims
|
|
TRPM7 RPSA Complex Regulates Pancreatic Cancer Cell Migration2020 · Frontiers in Cell
The document investigates the activity of specific elastin-derived peptide sequences (EDPs, elastokines), explicitly naming VG-6 and AG-9, and reports on their ability to stimulate cell migration (an...
2 claims
|
|
Terrestrial Microorganisms Cell Factories of Bioactive Molecules with Skin Protecting Applications.2019
The document is a review on bioactive molecules from terrestrial microorganisms used for skin protecting and anti-aging applications, specifically referencing the cosmetic and cosmeceutical sector....
2 claims
|
|
The Anti-Photoaging Activity of Peptides from i Pinctada martensii i Meat.2022 · Meat. Mar.
The document investigates the anti-photoaging activity of specific identified peptides (e.g., Phe-His, Ala-Leu, Met-Tyr, Ala-Gly-Phe, and Ile-Tyr-Pro) derived from Pinctada martensii. Critically, it...
3 claims
|
|
The Clinical Evidence-Based Paradigm of Topical Anti-Aging Skincare Formulations Enriched with Bio-AThe document is a review focusing on a specific bioactive peptide, SA1-III (KP1), and explicitly provides its full sequence (Ac-Met-Gly-Lys-Val-Val-Asn-Pro-Thr-Gln-Lys-NH2) and modifications...
3 claims
|
|
The Combined Anti-Aging Effect of Hydrolyzed Collagen Oligopeptides and Exosomes Derived from Human2024
The document investigates Hydrolyzed Collagen Oligopeptides (HCOPs) for anti-aging effects on Human Skin Fibroblasts (HSFs). This involves the restoration of the dermal extracellular matrix (ECM) and...
3 claims
|
|
The Effect of Anti-aging Peptides on Mechanical and Biological Properties of HaCaT Keratinocytes2017 · Journal of Peptide Research and Therapeutics
The document investigates the effects of 'anti-aging peptides,' specifically Acetyl Tetrapeptide-2 (P1) and Acetyl Hexapeptide-50 (P2). The text explicitly states that P1 is 'known as a stimulator of...
3 claims
|
|
The Effects of Crosslinking on the Rheology and Cellular Behavior of Polymer-Based 3D-Multilayered S2021
The document, although focused on cartilage scaffolds, explicitly discusses and characterizes 'elastin-like recombinant polymers (ELRs),' which are inherently peptide-based materials designed around...
2 claims
|
|
The Effects of a Novel Series of KTTKS Analogues on Cytotoxicity and Proteolytic Activity2019
The document investigates novel analogues of the cosmetic peptide KTTKS (palmitoyl pentapeptide-3), providing sequence and modification details (palmitoyl, acetyl, lipoyl). Although the study...
3 claims
|
|
The Efficacy and Safety of CollaSel Pro sup ® sup Hydrolyzed Collagen Peptide Supplementation withou2024 · Clin. Med.
The document investigates the effect of Hydrolyzed Collagen Peptides (HCPs) on skin elasticity and anti-aging properties in humans, providing quantitative results (mPa values for elasticity). The...
2 claims
|
|
The Elastin Receptor Complex A Unique Matricellular Receptor with High Anti-tumoral Potential2016 · Frontiers in Pharmacology
The document is centrally focused on bioactive elastin-derived peptides (elastokines) and their specific sequences (e.g., VGVAPG, GxxPG, YTTGKLPYGYGPGG). Although the context is cancer signaling...
3 claims
|
|
The Elastin Receptor Complex An Emerging Therapeutic Target Against Age-Related Vascular DiseasesFrontiers in Endocrinology
The document is a review focused on Elastin-Derived Peptides (EDPs, or elastokines), their consensus sequence (xGxxPG), and the Elastin Receptor Complex (ERC). It explicitly mentions 'current...
2 claims
|
|
The Functional Role of Extracellular Matrix Proteins in Cancer2022
The document reviews the Extracellular Matrix (ECM) and its degradation fragments ('matrikines,' which include peptides derived from elastin). Although the primary domain is cancer, it is highly...
2 claims
|
|
The Innovative Biomaterials and Technologies for Developing Corneal Endothelium Tissue Engineering S2023
The document is a review of biomaterials and bioactive materials for corneal endothelium tissue engineering scaffolds. While the focus is on corneal tissue, such reviews frequently detail specific...
2 claims
|
|
The Potential of Algae in the Nutricosmetic Sector.2023
This is a review of algae metabolites (including peptides) used in the nutricosmetic and anti-aging sectors. Anti-aging/anti-wrinkling activities frequently involve the stimulation of dermal matrix...
1 claim
|
|
The Reparative Effect of <i>Dendrobium officinale< i> Protocorms against Photodamage Cau2019 · Biol. Pharm. Bull.
The study uses 'Matrixyl' (a recognized matrikine messenger peptide) as a positive control at a specific concentration (10 mg/mL) in an in vivo anti-photoaging assay. This setup provides highly...
2 claims
|
|
The Role of Macrophages in the Infarcted Myocardium Orchestrators of ECM Remodeling2019 · Frontiers in Cardiovascular Medicine
The document reviews Extracellular Matrix (ECM) remodeling, focusing on the roles of macrophages, fibroblasts, and regulating signals (like TGFβ1, MMPs) in post-infarction repair and fibrosis....
3 claims
|
|
The Role of Lysyl Oxidase Enzymes in Cardiac Function and Remodeling2019
This review details the crucial mechanism of elastin maturation (cross-linking) mediated by Lysyl Oxidase (LOX) enzymes, which is central to elastin function. It explicitly mentions the biological...
2 claims
|
|
The Role of Mitochondria-Derived Peptides in Cardiovascular Diseases and Their Potential as Therapeu2021 · Targets. Int.
The document reviews specific small peptides (Mitochondria-Derived Peptides: Humanin, MOTS-c, SHLPs) and explicitly mentions studying 'modified and synthetic MDPs' for their therapeutic application...
1 claim
|
|
The Skin Aging Process and Anti-Aging StrategiesThe document is a review of the skin aging process and anti-aging strategies, focusing on repairing skin damage through stimulation of collagen production at the cellular level. Since loss of...
1 claim
|
|
The Use of Proteins, Lipids, and Carbohydrates in the Management of Wounds.2023
This is a comprehensive review on the use of proteins and biopolymers in wound healing, which involves the remodeling and production of the extracellular matrix (ECM), including elastin synthesis....
2 claims
|
|
The VGVAPG Peptide Regulates the Production of Nitric Oxide Synthases and Reactive Oxygen Species in2019
The document provides specific quantitative activity data (sequence: VGVAPG, cell type: mouse astrocytes, concentrations: 10 nM and 1 µM, outcomes: modulation of ROS/NO production) for a canonical...
3 claims
|
|
untitledThe document's table of contents includes an article titled 'The Use of Fish Elastin Hydrolyzate to Enhance Fibroblast Proliferation, Elastin Synthesis in Them, and Improve Human Skin Condition.'...
3 claims
|
|
The cell-elastin-elastase(s) interacting triade directs elastolysisFrontiers in Bioscience
The document reviews Elastin Peptides (EPs), referred to as 'potent matrikines' or 'elastokines' (Section 5). These peptides are the focus of the research goal, which seeks reported sequences tested...
3 claims
|
|
The distribution and function of elastin and elastic fibres in the canine cruciate ligament complexThe document investigates the biological effects of elastin degradation products (EDPs) containing the specific peptide motif 'VGVAPG' on canine ACL cells in vitro, resulting in increased...
2 claims
|
|
The elastin peptide VGVAPG increases CD4+ T-cell IL-4 production in patients with chronic obstructiv2021
The document identifies a specific elastin-derived peptide sequence (VGVAPG) and quantitatively characterizes its biological activity (modulation of IL-4 in CD4+ T-cells) mediated via the elastin...
2 claims
|
|
The modulation of dynamin and receptor endocytosis machinery using elastin-like polypeptidesThe document extensively utilizes and characterizes Elastin-Like Polypeptides (ELPs). Although the specific biological activity measured is receptor endocytosis and signaling, not native elastin...
3 claims
|
|
Therapeutic Potential of Annexin A1 Modulation in Kidney and Cardiovascular Disorders.2021
The document, a review on Annexin A1, explicitly identifies and lists specific N-terminal derived peptides (Ac2-26, Ac2-12, and Ac2-6) that are acetylated (a required modification detail). These...
1 claim
|
|
Therapeutic Potential of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Recovering From Muri2021 · Frontiers in Medicine
The study investigates tissue repair in emphysema and reports a specific quantitative outcome: hUC-MSCs conditioned medium increases messenger RNA expressions of elastin in lung fibroblasts. This...
2 claims
|
|
Therapeutic Potential of Neopyropia yezoensis An Updated Review2025 · Review. Mar.
This document is a review of the therapeutic potential of seaweed compounds, explicitly covering synthetic and recombinant peptides and their anti-aging activities. Elastin stimulation is a primary...
2 claims
|
|
Thrombospondin-1 Signaling Through the Calreticulin LDL Receptor Related Protein 1 Axis Functions anThe document reviews Thrombospondin-1 (TSP-1), a major regulator of the extracellular matrix (ECM). It discusses specific functional domains/sequences (N-terminal domain) and their roles in...
3 claims
|
|
Tissue Regeneration A Silk Road.2016
This is a review focused on silk fibroin (SF) proteins/peptides for various tissue regeneration applications, including skin, tendon, and ligament. SF structure is discussed (amino acid sequences,...
1 claim
|
|
Toll-like receptor 2 activation and serum amyloid A regulate smooth muscle cell extracellular matrix2017 · PLOS ONE
The document investigates the regulation of smooth muscle cell extracellular matrix, specifically focusing on insoluble elastin accumulation and tropoelastin expression (Eln mRNA). It tests defined,...
3 claims
|
|
Topically applied GHK as an anti-wrinkle peptide Advantages, problems and prospectiveThis review explicitly focuses on the peptide GHK (Glycyl-histidyl-lysine) and its modified forms (GHK-Cu, Pal-GHK). The text specifically states that GHK is a signal peptide 'capable of promoting...
3 claims
|
|
Topisches Anti-AgingProf. Dr.
The document is a comprehensive review article on topical anti-aging in dermatology, a field that heavily utilizes peptides designed to stimulate dermal matrix components (like elastin and collagen)....
3 claims
|
|
Transmembrane Peptides as a New Strategy to Inhibit Neuraminidase-1 Activation2020 · Frontiers in Cell
The document investigates interfering peptides (IntPep) designed to inhibit Neuraminidase-1 (NEU1). NEU1 is explicitly stated to be a key component of the Elastin Receptor Complex (ERC) and 'required...
3 claims
|
|
Treatment of Skin Aging and Photoaging with Innovative Oral Dosage Forms of Non-Hydrolized Carnosine2017
The document investigates the anti-aging effects of specific dipeptide sequences (Carnosine and Carcinine, including the non-hydrolyzed modification) on human skin fibroblasts. Although the abstract...
3 claims
|
|
Trending Anti-Aging Peptides2020
The document is a review of anti-aging peptides used in cosmetics, explicitly categorizing 'Signal peptides' as those that 'stimulate matrix protein production (such as collagen and elastin)'. It...
3 claims
|
|
Trends in the Development of Tailored Elastin-Like Recombinamer–Based Porous Biomaterials for Soft aThis document is a review focusing on Elastin-Like Polypeptides (ELPs) and Elastin-Like Recombinamers (ELRs). ELRs are defined, customized peptide sequences (and their modifications) whose...
3 claims
|
|
Tropoelastin inhibits vascular calcification via 67-kDa elastin binding protein in cultured bovine aJournal of Atherosclerosis and Thrombosis
The document explicitly tests the biological activity of a specific elastin-derived peptide sequence, VGVAPG. It provides the concentration range (0.1–1000 nM), the cell type (BASMCs), the assay...
3 claims
|
|
Tropoelastin and Elastin Assembly2021 · Frontiers in Bioengineering
This review focuses on tropoelastin structure and assembly. It explicitly discusses the use of synthetic peptides derived from tropoelastin's hydrophobic (e.g., VPGVG) and cross-linking domains,...
2 claims
|
|
Tumor Microenvironment Extracellular Matrix Alterations Influence Tumor Progression2020 · Frontiers in Oncology
This mini-review focuses on Extracellular Matrix (ECM) degradation and the role of ECM fragments, known as matrikines or matricryptins. These fragments include elastin-derived peptides, which are...
2 claims
|
|
Tumour cell blebbing and extracellular vesicle shedding key role of matrikines and ribosomal protein2019 · Journal of Cancer
The document investigates specific elastin degradation products (EDPs) – VGVAPG and AGVPGLGVG – and reports their quantitative biological outcomes (inducing cell blebbing, affecting calcium influx)...
3 claims
|
|
Turning a Collagenesis-Inducing Peptide Into a Potent Antibacterial and Antibiofilm Agent Against Mu2019 · Frontiers in Microbiology
The document investigates synthetic peptides (KTTKS and derivatives, including palmitoylation) known as matrikines for their 'collagenesis-inducing' behavior in human fibroblasts (HFF-1). While the...
3 claims
|
|
Uncoupling of Elastin Complex Receptor during In Vitro Aging Is Related to Modifications in Its Intr2015 · PLOS ONE
The document investigates the biological activity and signaling pathways triggered by specific elastin-derived peptides (EDP), which are known stimulators of matrix synthesis/elastogenesis. It...
3 claims
|
|
Unlocking the Health Potential of Microalgae as Sustainable Sources of Bioactive Compounds2021 · Compounds. Int.
The document is a comprehensive review on bioactive compounds from microalgae for human health applications. Although the provided excerpt focuses on pigments (fucoxanthin) and internal health...
2 claims
|
|
Unraveling Elastic Fiber-Derived Signaling in Arterial Aging and Related Arterial Diseases2025
This review focuses specifically on 'elastin-derived peptides' (EDPs) and their signaling role (via the elastin receptor complex, ERC) in arterial aging and disease. Although the documented activity...
3 claims
|
|
Use of Collagen in Cosmetic Products.2024 · Products. Curr.
This is a review on the use of collagen peptides (hydrolysates) in cosmetics to improve skin elasticity. While the specific elastin-stimulating sequences and quantitative outcomes are not detailed in...
2 claims
|
|
Usage of Synthetic Peptides in Cosmetics for Sensitive Skin.2021
The document is a review focusing on synthetic peptides used in cosmetics, specifically listing sequences (e.g., acetyl dipeptide-1 cetyl ester, palmitoyl tripeptide-5, palmitoyl tetrapeptide-7)...
3 claims
|
|
Use of Waste from the Food Industry and Applications of the Fermentation Process to Create Sustainab2024
This is a review focused on sustainable cosmetic ingredients, often derived through fermentation of food waste. The resulting bioactive materials frequently include peptides (hydrolysates) that are...
1 claim
|
|
Vascular elastic laminae anti-inflammatory properties and potential applications to arterial reconstFrontiers in Bioscience
The document reviews the composition and structure of arterial elastic laminae (elastin), explicitly listing core peptide repeat sequences (e.g., GVGVP, GGVP, GVGVAP) and a sequence bound by the...
3 claims
|
|
Why Venous Leg Ulcers Have Difficulty Healing Overview on Pathophysiology, Clinical Consequences, an2020 · Clin.
Med.
The document reviews the pathophysiology and treatment of Venous Leg Ulcers (VLU), a condition characterized by chronic inflammation and breakdown of the Extracellular Matrix (ECM). The text mentions...
3 claims
|
|
Wrinkle Reduction Using Tetrapeptide-68 Contained in an O W Formulation A Randomized Double-Blind Pl2024
The document identifies a specific tetrapeptide (Tetrapeptide-68, sequence GQVS) that was selected for its 'elastase inhibitory activity' and 'skin cell proliferating–promoting ability.' While the...
3 claims
|
|
Wrinkle-Improving Effect of Novel Peptide That Binds to Nicotinic Acetylcholine Receptor2024 · Receptor. Int.
The document reports the sequence (RRGVRR) and detailed quantitative outcomes of a peptide aimed at reducing wrinkles and enhancing skin elasticity. While the primary measured matrix protein is...
3 claims
|
|
untitledThe review covers biomimetic peptides used in dermatology/anti-aging. It explicitly identifies 'Signal peptides' that trigger increased expression of elastin (along with collagen and proteoglycans)....
3 claims
|
|
[A turning point in the knowledge of the structure-function-activity relations of elastin].2001
This document is a review dedicated to analyzing the structure-function-activity relationship of elastin and specific elastin-derived peptides (elastokines), including VGVAPG, PGAIPG, and related...
2 claims
|
|
Zur Pathogenese des Marfan-Syndroms Untersuchung der Matrix- Metalloproteinase-Regulierung nach Stim2005 · Journal of Molecular and Cellular Cardiology
The document investigates recombinant Fibrillin-1 peptide fragments containing the Glycin-x-x-Prolin-Glycin (GxxPG) consensus sequence, which is the binding motif for Elastin-Binding Protein (EBP)....
2 claims
|
|
untitledThe document is a review of cosmeceutical peptides and contains a dedicated section on 'Elastin modulating peptides.' It explicitly identifies Palmitoyl-pentapeptide (Pal-KTTKS) as stimulating...
3 claims
|
|
| Document | Claims |
|---|---|
acceptée sur proposition du jury: Prof. V. Hatzimanikatis, président du jury Prof. J. A. Hubbell, directeur de thèse Prof. T. Barker, rapporteur2009 · Cole Polytechnique F D Rale De Lausanne Epfl
The document investigates engineered peptide/protein delivery (IGF1 fused with a Factor XIIIa substrate sequence, derived from alpha2-plasmin inhibitor) to stimulate smooth muscle cell growth and...
3 claims
|
|
Arteriosclerosis, Thrombosis, and Vascular Biology Arterioscler Thromb Vasc Biol. 2025;45:00–00. DOI: 10.1161/ATVBAHA.124.3223502025 · University Of Cambridge
The document investigates the protective role of a specific peptide (C-type Natriuretic Peptide, CNP) against aortic aneurysm progression. A key outcome measured is the reduction of 'elastin...
3 claims
|
|
Relaxin receptor deficiency promotes vascular inflammation and impairs outward remodeling in arteriovenous fistulasUtrecht University
The document investigates the role of Relaxin (RLN), a 6-kDa peptide hormone, and its receptor (RXFP1) on vascular remodeling, providing explicit quantitative data on elastin content (43% increase)...
3 claims
|
|
| Document | Claims |
|---|---|
US-10004779-B22018
The document identifies a specific peptide sequence (Val-Gly-Val-Ala-Pro-Gly, SEQ ID NO: 19) used in conjunction with other agents for its role related to elastic fibers. Furthermore, the description...
3 claims
|
|
US-10081667-B22018
The document provides specific peptide sequences (Elastin-Like Polypeptides, VPGXG repeats, various lengths/ratios, SEQ ID NOs 2-13) that are fundamental components/mimics of elastin. Although the...
3 claims
|
|
US-10137156-B22018
The document reports specific sequences of Elastin-Like Polypeptides (ELPs) based on the VGVPG motif (e.g., [VGRGD(VGVPG)6]n, SEQ ID NO: 4) and provides quantitative data regarding their structure,...
3 claims
|
|
US-10167325-B22019
The patent claims and describes specific peptide sequences (e.g., IGVAPG, VGAMPG) and modifications (N-terminus acetylation) that are asserted to stimulate elastogenesis and act as ligands for...
3 claims
|
|
US-10239902-B22019
The document provides specific peptide sequences (e.g., KVK, RGD) of relevant lengths (2-5 residues) and details required modifications (palmitoylation, stearylation, conjugation to ascorbic acid)....
3 claims
|
|
US-10258556-B22019
The document discloses a specific peptide sequence (ProAspSerThrGluAlaLys, SEQ ID NO: 1) and provides experimental evidence (FIG. 1 and description) showing its effect on enhancing elastin (ELN) mRNA...
2 claims
|
|
US-10272059-B22019
The document claims specific ratios of free amino acids (Glycine, L-proline, L-alanine, L-valine, L-leucine, L-lysine) that are the fundamental building blocks of known elastin-stimulating peptides....
3 claims
|
|
US-10434340-B22019
The document, a patent, directly discusses and claims the use of 'palmitoyl tetrapeptide 7' for treating skin conditions associated with aging, such as 'loss of elasticity' and 'fine lines and...
2 claims
|
|
US-10463592-B22019
The document provides specific short peptide sequences and modifications (acetylation, amidation) designed for dermal anti-aging effects, focusing on promoting fibroblast growth, hyaluronic acid...
3 claims
|
|
US-10478461-B22019
The document is a patent describing the use of cellular extracts containing polypeptides/proteins for improving skin health, cosmetic appearance, anti-aging, and wound healing. These therapeutic...
2 claims
|
|
US-10596095-B22020
The document identifies a specific peptide (P-113/SEQ ID NO: 1) used for anti-aging and improving skin elasticity, a highly related domain to elastin stimulation. It provides quantitative findings...
3 claims
|
|
US-10588844-B22020
The document introduces a specific modified peptide sequence (Oleanoyl-KVK) and claims anti-elastase activity. While the research goal focuses on elastin-stimulating activity, anti-elastase activity...
2 claims
|
|
US-10596230-B22020
The document defines specific Elastin-Like Peptide (ELP) sequences (VPGXG repeats, V:A:G ratio, and precise lengths like 90, 120, or 144 units). Although the patent focuses on using these ELPs for...
3 claims
|
|
US-10610479-B22020
The document explicitly identifies a specific modified peptide, palmitoyl tripeptide 38, and claims its function is to enhance elastin, directly addressing the core requirement of finding reported...
3 claims
|
|
US-10668000-B22020
This patent describes specific peptide formulas (X-Pro-Pro-Xaa-Y, like Myr-PPL-OH and Myr-PPR-OH) and explicitly claims their use to 'stimulate the synthesis of... elastin.' It provides the required...
3 claims
|
|
US-10688156-B22020
The document describes a therapeutic agent incorporating a specific Elastin-Like Peptide (ELP) sequence (VPGXG repeat units, SEQ ID NO: 3). It provides quantitative outcomes (dosing 1-10 mg/kg/day,...
3 claims
|
|
US-10822382-B22020
The document discloses specific polypeptide sequences (HSP90a, HPf, HPfΔC1, HPfΔC2) intended for topical use to improve skin conditions, specifically mentioning 'skin elasticity' and 'wrinkles.'...
2 claims
|
|
US-10844101-B22020
This patent directly describes and claims novel synthetic peptides (e.g., VGLMPG, IGLMPG) and modifications (N-acetylation, metal complexation) explicitly designed to serve as ligands for elastin...
3 claims
|
|
US-10869948-B22020
The document is a patent describing an 'elastin peptide' composition resulting from enzymatic hydrolysis, which is explicitly claimed to 'significantly increase the amount of the elastin' in damaged...
3 claims
|
|
US-10905734-B22021
The document describes numerous specific peptide sequences (SEQ ID NOs 15-775) derived from pea and rice proteins and explicitly states that these peptides have been shown to have an effect on...
3 claims
|
|
US-10925922-B22021
The document, a patent describing cosmetic/therapeutic peptides derived from plant proteins, explicitly states that the identified peptides 'have been shown to have an effect on elastin and collagen...
3 claims
|
|
US-10934343-B22021
The patent provides specific, designed tropoelastin-derived polypeptide sequences (Elastin-like Polypeptides, including SEQ ID NO: 8) and defined repeating units/modifications (e.g., Cysteine...
3 claims
|
|
US-10961317-B22021
The document explicitly discloses specific, long Elastin-Like Peptide (ELP) sequences (e.g., G(VPGAG)192Y) and their modifications (fusion to scFv). While the disclosed function is anti-cancer...
3 claims
|
|
US-10961523-B22021
The document lists specific, modified peptide sequences (Cu-GHK tripeptide, palmitoyl-KTTKS pentapeptide, palmitoyl-GHK, palmitoyl-GQPR) that are prototypical agents studied and used for stimulating...
2 claims
|
|
US-11001607-B22021
The document, a patent, explicitly claims and describes novel peptides (e.g., Pal-K(Ac)GH) that are active in stimulating the synthesis of elastin, which directly addresses the research goal of...
3 claims
|
|
US-11007385-B22021
The patent directly addresses the research goal by focusing on methods and compositions (fish egg cellular extracts) for 'stimulating elastin production' in skin cells (fibroblasts). While the active...
1 claim
|
|
US-11084867-B22021
The document explicitly discusses the use of 'tropoelastin or elastin derived peptide' for tissue healing. While the provided abstract and claims focus on the delivery system and the full protein,...
3 claims
|
|
US-11103558-B22021
The document explicitly defines specific sequences and lengths of Elastin-Like Peptides (ELPs), such as VPGXG repeating units (90, 120, 144 times) used in fusion proteins. While the primary activity...
3 claims
|
|
US-11123578-B22021
The document identifies a specific modified peptide, Palmitoyl tetrapeptide-7, and claims its use in compositions that increase skin elasticity and firming. Increased elasticity is directly linked to...
3 claims
|
|
US-11149262-B22021
The document describes defined polypeptide sequences (Botulinum toxin binding domains and fragments, e.g., Hc/A, Hcn/A) and reports their activity in modulating gene expression in primary human...
3 claims
|
|
US-11155579-B22021
The patent directly claims that the described peptides (e.g., SEQ ID NOs: 2-15) have advantageous effects in 'increasing production of... elastin.' Identifying these sequences and their claimed...
3 claims
|
|
US-11306121-B22022
The document introduces a specific peptide sequence (SEQ ID NO: 1) tested for anti-wrinkle cosmetic applications. While the abstract focuses on muscle relaxation and collagen stimulation (Claim 10),...
3 claims
|
|
US-11471395-B22022
The document is a patent detailing specific peptide sequences (SEQ ID NOs 1-6) derived from fish skin and providing quantitative evidence of their activity on human cells. Although the primary...
3 claims
|
|
US-11523982-B22022
The document claims that compositions containing marine extracts stimulate the production of elastin (elastin-stimulating activity). While it does not identify specific peptide sequences or detailed...
3 claims
|
|
US-11571378-B22023
The document identifies specific modified peptide sequences (palmitoyl dipeptide-7, acetyl tetrapeptide-11) along with concentrations, targeting 'extracellular matrix repair and renewal processes.'...
3 claims
|
|
US-11596813-B22023
The document explicitly identifies a modified peptide, palmitoyl tetrapeptide 7, and claims its use for improving skin elasticity and firmness. This directly addresses the research goal of...
3 claims
|
|
US-11607445-B22023
The document describes and lists specific sequences (SEQ ID NOs 1-9) of Elastin-Like Polypeptides (ELPs) and their modified conjugates (C-peptide bound to ELP, K8, K9-C-peptide). Although the primary...
3 claims
|
|
US-11612556-B22023
The document, a patent, explicitly defines and claims novel modified peptide sequences (e.g., Pal-K(P)-HG-OH, including palmitoylation and side-chain modification) that are designed and stated to...
3 claims
|
|
US-11628133-B22023
The document provides a specific peptide sequence (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2), its modifications (D-amino acids, C-terminal amide), concentration (0.1-1 μM), cell type (fibroblasts), and...
3 claims
|
|
US-11679284-B22023
The document, a patent application concerning cosmetic compositions, explicitly discloses the use of a specific modified peptide sequence (palmitoyl tetrapeptide-7) in formulations intended to...
3 claims
|
|
US-11707500-B22023
The document is a patent describing specific peptide sequences (SEQ ID NOs provided) that are used for the prevention of human skin aging. The description explicitly states that these peptides have...
3 claims
|
|
US-11739126-B22023
The document provides specific peptide sequences and defined lengths for Elastin-Like Polypeptides (ELPs), which are highly relevant structural derivatives of elastin (e.g., (GVGVP)n). Although the...
3 claims
|
|
US-11746125-B22023
The patent explicitly claims that the described peptides (e.g., RPIK, PRPIK, and others listed as SEQ ID NOs 2-15) are used for 'increasing production of elastin' (elastin-stimulating activity). This...
3 claims
|
|
US-11850299-B22023
This patent provides specific modified peptide sequences (palmitoyl dipeptide-7, acetyl tetrapeptide-11) and their modifications, lengths, and tested concentrations, all critical components required...
3 claims
|
|
US-11951203-B22024
The document provides specific peptide sequences (acetyl hexapeptides, Lys-Pro) and modifications (acetylation, complexation) intended for use in skin anti-aging/wrinkle reduction. This biological...
3 claims
|
|
US-12064494-B22024
The document identifies a specific, chemically modified oligopeptide, 'palmitoyl sh-tripeptide-4 amide,' used in anti-aging and aesthetic skin formulations (0.0001%-10% w/w). Although the abstract...
3 claims
|
|
US-12161745-B22024
The document discloses specific modified peptide sequences (e.g., Pal-His-Tyr-Arg-Ala-NH2) intended for anti-aging applications, specifically resulting in 'skin firming' and reducing 'sagginess.'...
3 claims
|
|
US-12186420-B22025
The document describes a specific peptide sequence (QHREDGS) used in cosmetic compositions aimed at improving skin appearance. Crucially, Claim 1 explicitly states that the improvement includes...
3 claims
|
|
US-12214009-B22025
The patent explicitly claims compositions and methods for 'stimulating elastin and/or collagen production' using specific peptides (tripeptide-1, hexapeptide-11, hexapeptide-12, hexapeptide-38,...
3 claims
|
|
US-12286461-B22025
The document provides specific peptide sequences (X, Y, and fused polypeptides) and structural modifications (Acetylation) intended to treat skin and tissue fibrosis by regulating the Extracellular...
3 claims
|
|
US-12371705-B22025
The document defines a specific partial human elastin peptide sequence (SEQ ID NO: 25) intended for use in skin care compositions. It reports in vitro testing results (non-cytotoxicity, upregulation...
3 claims
|
|
US-12391912-B22025
The document explicitly discloses sequences (SEQ ID NOs 1-3) for 'elastin-like peptides (ELPs)' and related disordered polypeptides, fulfilling the requirement to capture peptide sequences related to...
3 claims
|
|
US-12421277-B22025
The document discloses a specific peptide sequence (YLP) and quantitative claims regarding its anti-aging activity (increasing collagen and hyaluronic acid levels) on skin cells. Although...
2 claims
|
|
US-2002082196-A12002
The document lists several novel peptide sequences (SEQ ID NO: 4-8) with specified modifications (N-terminal acetylation) that are claimed to have 'wound healing activity.' Since elastin synthesis is...
3 claims
|
|
US-2002165185-A12002
The patent discloses novel HICP polypeptides (e.g., SEQ ID NO:2) and explicitly claims that these proteins/peptides can modulate 'extracellular matrix production' (Claim 29, part vi). Elastin is a...
3 claims
|
|
US-2003007938-A12003
The document describes the composition and use of ionic metal-peptide complexes derived from elastin hydrolysates (elastin peptides) complexed with Copper (II) for stimulating growth and repair. This...
2 claims
|
|
US-2003166510-A12003
The patent directly addresses the mechanism of interest (accelerating skin remodeling by enhancing the skin's production of collagen and elastin, paragraph [0004]). It specifies the use of short,...
3 claims
|
|
US-2004002449-A12004
The document provides specific peptide sequences (METH1, METH2, and various TSP domains/homologs, identified by SEQ ID NOs) derived from the thrombospondin (TSP) family, which are key components and...
2 claims
|
|
US-2004120918-A12004
The document explicitly claims cosmetic compositions containing the peptide sequence Val-Gly-Val-Ala-Pro-Gly (VGVAPG, SEQ ID NO: 1) and N-acyl derivatives thereof (specifically N-palmitoyl-VGVAPG,...
2 claims
|
|
US-2004141939-A12004
The document proposes specific peptide sequences (e.g., Lys-Leu-Asp-Ala-Pro-Thr) and their derivatives for use in compositions designed to reinforce the extracellular matrix. It explicitly claims...
3 claims
|
|
US-2004162232-A12004
The patent claims compositions containing specific peptide sequences derived from elastin (e.g., GXXPG, PGGVLPG, VGVVPG, IGLGPGGV) that are explicitly used to stimulate the endogenous production and...
3 claims
|
|
US-2004258676-A12004
The document defines comprehensive screening methods, cell models (fibroblasts, keratinocytes), and molecular targets (LOX, Tropoelastin) specifically aimed at identifying active principles that...
3 claims
|
|
US-2005054578-A12005
The document, specifically the Abstract, Claims (e.g., Claim 23 mentioning 'increased mRNA levels in skin cells' and 'increased elasticity'), and the Description (referencing FIG. 1 showing...
3 claims
|
|
US-2005059599-A12005
The document, a patent, directly claims the use of numerous specific peptide sequences (listed as SEQ ID 1 through SEQ ID 41) for 'enhancing tissue elasticity' and explicitly claims 'stimulating...
3 claims
|
|
US-2005124545-A12005
The document discloses specific peptide sequences (e.g., Arg-Asp-Phe-Thr-Lys-Ala-Thr-Asn-Ile-Arg-Leu-Arg-Phe-Leu-Arg) intended to increase the expression of extracellular matrix (ECM) proteins to...
3 claims
|
|
US-2005239710-A12005
The document details peptide sequences intended to inhibit matrix metalloproteinases (MMPs) for applications like discouraging wrinkling and encouraging healthy skin. Since MMPs, including MMP-2, are...
3 claims
|
|
US-2006013794-A12006
The document identifies specific peptide sequences (Arg-Gly-Ser and variants), relevant modifications (acetylation/acylation), and concentration ranges intended for use in stimulating extracellular...
1 claim
|
|
US-2006045894-A12006
The document explicitly identifies a modified peptide, 'palmitoyl pentapeptide-3,' and claims its activity is to 'stimulate production of collagen and elastin in skin.' This directly provides a...
1 claim
|
|
US-2006264375-A12006
The document explicitly discusses the use of elastin-derived peptides (specifically naming ProK60 and E91) as stimulators of elastogenesis. It confirms that these peptides are known to stimulate the...
3 claims
|
|
US-2007003536-A12007
The document explicitly states that the compositions 'promote synthesis of collagen and elastin.' The claims include protein/peptide sources (superoxide dismutase, glutathione, soybean protein,...
2 claims
|
|
US-2007031367-A12007
The document explicitly identifies specific modified peptides—palmitoyl pentapeptide-3 and palmitoyl tetrapeptide-3—that are claimed to stimulate the production of elastin in skin. This directly...
2 claims
|
|
US-2007086966-A12007
The document identifies a specific, modified peptide sequence (palmitoyl-gly-his-lys) used in an anti-aging/rejuvenating cosmetic context, which is highly relevant to research on elastin-stimulating...
2 claims
|
|
US-2007166267-A12007
The document provides specific short chain peptide sequences (e.g., Phe-Ala-Leu-Leu-Lys-Leu) and required modifications (palmitoylation/acylation, acetylation) at defined concentrations (0.001% to...
3 claims
|
|
US-2007218003-A12007
The document provides specific polypeptide sequences (via SEQ ID NOs) derived from DANCE, which are claimed to be regulators of elastic fiber formation (e.g., having lysyl oxidase-binding activity or...
2 claims
|
|
US-2007237735-A12007
The patent claims peptides (oligopeptides of 20 AA or less, including Pal-VGVAPG) that correspond to fragments of extracellular matrix proteins, specifically naming 'elastin' and 'tropoelastin'...
2 claims
|
|
US-2007286885-A12007
The document explicitly identifies and claims a specific elastin pentapeptide sequence (VGVPG) and details its modifications (incorporation into various block copolymers and conjugates). Although...
3 claims
|
|
US-2008050459-A12008
The document explicitly identifies and claims the use of Oligopeptide-5 as a 'pro-Elastin oligopeptide.' Although it lacks specific quantitative in vitro assay data (sequence, cell type, % increase),...
3 claims
|
|
US-2008050346-A12008
The document, a patent, directly addresses the research goal by claiming and listing numerous specific synthetic peptide sequences (SEQ ID NOs 2, 47-49, 51-56, 58-63) that are defined as 'elastogenic...
3 claims
|
|
US-2008058261-A12008
The document identifies specific short peptide sequences (including modifications like retro-inverso and reduced peptide bonds) derived from tropoelastin. While the reported activity is protease...
3 claims
|
|
US-2008081034-A12008
The document explicitly targets the promotion of elastin synthesis and the inhibition of elastase, which directly aligns with the research goal of finding elastin-stimulating activity. Although...
3 claims
|
|
US-2008081082-A12008
The document, a patent application for topical compositions, explicitly claims to 'promote synthesis of collagen and elastin.' While the listed components are primarily complex protein sources...
1 claim
|
|
US-2008161229-A12008
The patent identifies oligopeptides (derived from nucleoprotein/DNA hydrolysis, fractions 1000-3000 Da) as active ingredients in cosmetics targeting cellular stimulation and anti-wrinkle effects....
1 claim
|
|
US-2008181974-A12008
The document names specific, modified peptides (e.g., acetyl hexapeptide 3, palmitoyl oligopeptide pentapeptide 3, palmitoyl tetrapeptide 7) which are identified as active agents intended to improve...
3 claims
|
|
US-2008194476-A12008
The patent claims the avocado peptide extract functions as a 'specific elastase inhibitor' (Claim 30). Although it provides composition rather than specific individual sequences, elastase inhibition...
2 claims
|
|
US-2008227725-A12008
The document identifies specific peptide sequences ((AA)n-Arg-Gly-Ser-(AA)n, including Arg-Gly-Ser when N=0) and modifications (acetylation, amidation) claimed for anti-aging effects. The described...
3 claims
|
|
US-2008260869-A12008
The document explicitly names specific modified peptides, including 'dipeptide valyl-tryptophane' (VW) and 'palmitoyl tetrapeptide-3' (Pal-Gly-Gln-Pro-Arg), and claims that the composition containing...
3 claims
|
|
US-2008292651-A12008
This patent discloses specific modified peptides ('palmitoyl wheat protein hydrolysate,' 'tripeptide' identified as glutathione or dipeptide diaminocutyroyl benzylamide diacetate) used in...
3 claims
|
|
US-2008306001-A12008
The patent explicitly claims novel peptides (referenced by SEQ ID NOs) and compositions designed to stimulate the synthesis of structural components of the extracellular matrix, specifically...
3 claims
|
|
US-2009012002-A12009
The document is a patent describing novel peptides and their modifications (acetylation, amidation) for use in treating cutaneous aging. Since anti-aging therapies often target the stimulation of...
3 claims
|
|
US-2009054346-A12009
The document is a patent specifically claiming and describing the peptide sequence Leu-Glu-His-Ala (LEHA) as an elastin production-enhancing agent. This directly addresses the research goal of...
3 claims
|
|
US-2009068219-A12009
This patent identifies specific oligopeptides (Human Oligopeptide-9, Oligopeptide-4, Oligopeptide-5) used in anti-aging applications. The description explicitly mentions the role of these...
2 claims
|
|
US-2009082280-A12009
The document is a patent claiming novel synthetic peptide sequences (VGAMPG, VGLSPG, etc., and linked dimers) that are specifically designed and claimed to stimulate elastogenesis...
3 claims
|
|
US-2009099098-A12009
The document identifies a specific peptide sequence (H-Lys-Glu-Asp-OH) that enhances vascular wall durability and capillaries resistance, using vascular wall explants for study. Since elastin is...
1 claim
|
|
US-2009136595-A12009
The document details specific acylated oligopeptide sequences (e.g., Palmitoyl hexapeptide-6: Phe-Ala-Leu-Leu-Lys-Leu) and their concentration ranges, intended for stimulating 'dermal fibroblast...
3 claims
|
|
US-2009137458-A12009
The document describes methods utilizing ionic metal-peptide complexes (addressing the 'metal complexation' modification) to accelerate skin remodeling, explicitly stating that this mechanism...
3 claims
|
|
US-2009137783-A12009
The document defines novel polypeptides (SEQ ID NOs provided implicitly) and lists diseases/conditions relevant to extracellular matrix remodeling, such as wound healing, scar formation, and...
3 claims
|
|
US-2009170182-A12009
The document describes a polypeptide (Lopap) and its functional derivatives (including various chemical modifications like acetylation and myristoylation) used as an anti-aging agent. Critically, the...
3 claims
|
|
US-2009186826-A12009
The document explicitly describes and claims the use of the peptide Palmitoyl-Val-Gly-Val-Ala-Pro-Gly (SEQ ID NO: 1), a well-known elastin mimetic peptide (VGVAPG), for treating signs of aging,...
3 claims
|
|
US-2009281044-A12009
The document, a patent, directly addresses the research goal by defining specific elastin peptide sequences (PGGVLPG, VGVVPG, IGLGPGGV, and the GXXPG motif) derived from an elastin digest. It...
3 claims
|
|
US-2010016417-A12010
The document explicitly names specific elastin-derived peptides, ProK60 and E91, which are characterized as 'stimulators of elastogenesis.' It also mentions the cell types used (primary cultures of...
2 claims
|
|
US-2010022455-A12010
The document defines and uses specific Elastin-Like Peptide (ELP) sequences (e.g., VPGXG repeats, SEQ ID NO: 3, and SEQ ID NO: 22) as components of therapeutic agents. While the primary function...
3 claims
|
|
US-2010034758-A12010
The document explicitly describes novel modified peptide sequences (Lys-Thr-Thr-Lys-Ser core sequence linked to various triterpenoid acids like Oleanolic acid or Ursolic acid) intended for...
3 claims
|
|
US-2010040710-A12010
The document directly addresses the stimulation and formation of elastic fibers (elastogenesis) by targeting lysyl oxidase-like (LOXL) activity and elastin expression, which is central to the...
3 claims
|
|
US-2010136103-A12010
The document details specific peptide sequences and their modifications used in anti-aging compositions targeting dermal extracellular matrix (ECM) components, specifically claiming stimulation of...
2 claims
|
|
US-2010145255-A12010
The document identifies a modified peptide ('acetyl hexapeptide') used specifically for skin rejuvenation and wrinkle reduction. Although the exact sequence and quantitative elastin data are not...
3 claims
|
|
US-2010184637-A12010
The document discloses specific peptide sequences (SEQ ID No. 1, 2) along with relevant modifications (amidation, acetylation) and concentrations, intended for anti-aging and dermatological use. The...
2 claims
|
|
US-2010215657-A12010
The patent provides specific amino acid sequences (SEQ ID NOs) of large polypeptides/fusion proteins intended for therapeutic use in age-related conditions, including 'wrinkles' and 'skin atrophy.'...
3 claims
|
|
US-2010247454-A12010
The document describes methods and compositions for stimulating elastogenesis in relevant cell types (human dermal fibroblasts, SMCs). While the primary active agents are mineral complexes, the...
3 claims
|
|
US-2010310484-A12010
The document provides numerous detailed peptide sequences (SEQ ID NOs 3-13) and complex modifications (lipoyl, potential palmitoyl, acetyl, hexyl, decyl) intended for treating aging-related skin...
3 claims
|
|
US-2010311668-A12010
The document introduces specific tetrapeptide sequences (GEPG, GPPG, PGPP, PKEK) and their N-acyl derivatives for use as anti-aging actives, targeting conditions like wrinkles and sagging skin. While...
3 claims
|
|
US-2011039776-A12011
The document defines specific sequences and modifications of Elastin-Like Peptides (ELPs), primarily based on VPGXG repeats (Claims 25-32). While the reported quantitative outcomes relate to drug...
3 claims
|
|
US-2011052517-A12011
The patent claims topical application of a metal-complexed peptide (SEQ ID NO:1) derived from yeast extracts for various anti-aging benefits, including 'increase in and/or preventing loss of skin...
3 claims
|
|
US-2011064832-A12011
The document explicitly identifies a specific modified peptide sequence, palmitoyl tetrapeptide-7, which is claimed to treat skin aging, firm skin, and reduce wrinkles. These activities are strongly...
3 claims
|
|
US-2011081322-A12011
The document, a patent application, explicitly identifies and lists numerous synthetic peptide sequences (e.g., SEQ ID NOs 47, 48, 49, 51, 58) that are claimed to act as 'elastogenic agents' and...
2 claims
|
|
US-2011086060-A12011
The document explicitly identifies specific, modified peptide sequences (e.g., N2-(1-oxohexadecyl)-L-lysyl-L-valyl-L-lysine and Palmitoyl-Lys-Thr-Thr-Lys-Ser) and attributes elastin-stimulating...
3 claims
|
|
US-2011091398-A12011
The document describes a novel composition comprising a specific peptide (SEQ ID No. 1) linked to a modification (oleanolic acid) used for treating skin aging. The stated mechanism of action...
3 claims
|
|
US-2011092422-A12011
The document defines specific Elastin-Like Peptide (ELP) sequences (e.g., (VPGXG) 47-101 and variants) which are directly relevant to the structure of elastin-related peptides. While the document...
3 claims
|
|
US-2011092431-A12011
The document provides explicit peptide sequences (e.g., Pro-Val-Val-Val-Pro-Pro) developed for skin aging and collagen production promotion. Although the activity claimed is collagen, this target...
3 claims
|
|
US-2011172400-A12011
The document describes isolated antibody single variable domain polypeptides (sequences/CDRs) and their activity. While the primary goal is CD40L antagonism, the description explicitly details how...
3 claims
|
|
US-2011237516-A12011
The patent directly identifies multiple novel peptide sequences (e.g., VGAMPG, IGLSPG, VGLSPG) and related linked peptides, and explicitly claims their utility and activity in stimulating...
3 claims
|
|
US-2011268812-A12011
The document lists numerous specific peptide sequences (including known elastin fragments like VGVAPG) and chemical modifications (e.g., palmitoylation) used in cosmetic compositions aimed at slowing...
3 claims
|
|
US-2012015064-A12012
The document explicitly identifies a specific modified peptide, 'palmitoyl tetrapeptide-7,' and its use in topical compositions for skin firming and reducing wrinkles (anti-aging). This directly...
2 claims
|
|
US-2012046640-A12012
The document identifies specific peptide sequences derived from elastin (VGVPG) and ECM components (SIKVAV, YIGSRG), detailing their structural context and modifications (e.g., incorporation into ABA...
3 claims
|
|
US-2012094919-A12012
The document provides specific tripeptide sequences and modifications (e.g., Palm-Lys-Val-Lys-OH, Tetradecyl-NH—C(O)-Dab-Val-Dab-OH) which are primary data requirements. Although the patent...
3 claims
|
|
US-2012114577-A12012
The document describes novel peptide sequences (SEQ ID NO:1 + variants) designed to mimic TGF-β activity, specifically claiming efficacy for 'wrinkle improvement.' It also explicitly lists required...
3 claims
|
|
US-2012178901-A12012
The document discloses peptide sequences (SEQ ID NOs: 1-4) and their use in promoting tissue remodeling, specifically focusing on angiogenesis and wound healing. Although the primary quantitative...
3 claims
|
|
US-2012213845-A12012
The document, a patent in the anti-aging domain, explicitly mentions specific, modified peptides (Palmitoyl Oligopeptide, Palmitoyl Tetrapeptide-7) used as fine line reducers. Although the primary...
2 claims
|
|
US-2013143802-A12013
Document focuses on Elastin-Like Peptides (ELPs) as fusion partners to enhance drug pharmacokinetics (PK). While the tested outcome (PK enhancement) is not elastin *stimulation*, the document...
3 claims
|
|
US-2013295122-A12013
The patent directly names specific peptide sequences (PGGVLPG, VGVVPG, IGLGPGGV, GXXPG) and claims they stimulate lysyl oxidase production and enhance elasticity, which is a direct measure of...
3 claims
|
|
US-2014044655-A12014
The document is a patent describing novel peptides (SEQ ID NOs 1-6) claimed to activate extracellular matrix (ECM) protein synthesis in the skin, which is the mechanism for elastin stimulation....
3 claims
|
|
US-2014100170-A12014
The document explicitly identifies several synthetic peptide sequences (e.g., VGAMPG, IGLSPG, VGLSPG, IGAMPG) and linked dimers that are claimed to stimulate elastogenesis and interact with the...
3 claims
|
|
US-2014155335-A12014
The document, while focusing primarily on non-peptidic polyphenols (ellagic and tannic acid) for elastin protection, explicitly mentions that 'A proteolytic digest of elastin to provide a mixture of...
3 claims
|
|
US-2014206842-A12014
The document identifies a specific peptide sequence (SEQ ID NO: 1: Lysyl-Threonyl-Threonyl-Lysyl-Serine, KTTKS) and its modifications (Triterpenoid peptides, lipoic acid) used for dermal matrix...
3 claims
|
|
US-2014234242-A12014
The document explicitly identifies a relevant modified peptide sequence (Palmitoyl tetrapeptide-7) used in compositions for skin firming and wrinkle reduction. These activities are directly linked to...
3 claims
|
|
US-2014255951-A12014
The document focuses on Lysyl Oxidase-Like 2 (LOXL2), an enzyme essential for elastin cross-linking, which is an adjacent biochemical domain to elastin stimulation. It provides a specific short...
3 claims
|
|
US-2014271524-A12014
The document is a patent detailing cosmetic compositions using specific peptide sequences and modifications (e.g., palmitoyl oligopeptide, acetyl-hexapeptide-8) for anti-aging, explicitly mentioning...
1 claim
|
|
US-2014296155-A12014
The document provides specific peptide sequences and modifications required by the goal, namely palmitoyl pentapeptide (KTTLS) and hydrolyzed serecin, used in a formulation targeting skin matrix...
1 claim
|
|
US-2014348894-A12014
The document identifies and specifies an Elastin-Like Polypeptide (ELP) sequence domain, (VPGXG)n (SEQ ID No: 2), and mentions modifications (Lysine inclusion for crosslinking). This sequence is...
3 claims
|
|
US-2014363563-A12014
The document explicitly identifies and utilizes blocks of the elastin pentapeptide sequence VGVPG (SEQ ID NO: 1) as part of a novel copolymer structure. The research goal requires capturing peptide...
2 claims
|
|
US-2014371154-A12014
The document describes novel peptides (SEQ ID NOs: 1-4) intended for use in wound healing and tissue regeneration, which are adjacent domains to elastin stimulation. Although the primary claimed...
3 claims
|
|
US-2014377390-A12014
The document is a patent describing a cosmetic composition for combating skin aging that utilizes a specific, proprietary peptide (SEQ ID NO: 1). Peptides used for anti-aging often target the...
3 claims
|
|
US-2015004184-A12015
The document, a patent, directly identifies specific peptide sequences (e.g., PGGVLPG (SEQ ID No. 47), VGVVPG (SEQ ID No. 48), IGLGPGGV (SEQ ID. No. 49)) and explicitly claims they have...
3 claims
|
|
US-2015031604-A12015
The document provides detailed sequences and complex modifications (acetylation, cyclization, non-natural amino acids) of peptides, which are essential structural data points for the research goal....
3 claims
|
|
US-2015031633-A12015
The document describes novel peptide sequences (e.g., (Val-Gly-Val-Ala-Pro-Gly)n, n>=3) that are explicitly claimed to bind to the 'elastin-binding receptor protein' (EBP). Although the main claimed...
3 claims
|
|
US-2015056295-A12015
The document describes methods for restoring aged skin and improving cosmetic appearance using extracts and purified components, including specific polypeptides. Elastin stimulation is a common...
1 claim
|
|
US-2015093346-A12015
The document explicitly discloses a specific modified peptide sequence, Palmitoyl tetrapeptide-7, which is claimed to increase skin's elasticity and firmness. Since increased elasticity is directly...
2 claims
|
|
US-2015110755-A12015
This patent explicitly claims and lists numerous specific peptide sequences (e.g., PGGVLPG, VGVVPG, various VGAPG/IGAPG variants, including dimeric forms) as components of 'elastogenic compositions'...
3 claims
|
|
US-2015132235-A12015
The document provides specific peptide sequences (SEQ ID No 2) with known modifications (pGlu, Cys residues, C-terminal amide) and concentrations (e.g., 0.05 μM to 0.50 μM). Crucially, the patent...
3 claims
|
|
US-2015148297-A12015
The document is a patent describing a modified peptide (SEQ ID No. 1 linked to oleanolic acid) tested on human fibroblasts for skin firming and ECM regulation. Claim 5 mentions increasing Lysyl...
3 claims
|
|
US-2015218280-A12015
The document defines and utilizes specific Elastin-Like Peptide (ELP) sequences (e.g., SEQ ID NOs 6, 7, 14) which are core components of the research goal (peptide sequences tested for elastin...
3 claims
|
|
US-2015232523-A12015
The document is a patent describing synthetic peptide sequences (PEDF derivatives, including modified versions 'MO') intended to treat skin aging and loss of elasticity by stimulating the...
3 claims
|
|
US-2015307546-A12015
The document provides explicit peptide sequences, modifications (fusion constructs), and lengths of Elastin-Like Polypeptides (ELP), specifically VPGVG repeats (SEQ ID NOs 1, 3, 4, 5, 20-60 repeats)....
3 claims
|
|
US-2015322114-A12015
The document explicitly lists several elastin-like peptide (ELP) sequences (VPGVG, VPGDG, VPGEG, VGIPG, VPGIG) which are critical comparison or control sequences for elastin-stimulating studies....
3 claims
|
|
US-2016089415-A12016
The document explicitly names a synthetic peptide sequence, Val-Gly-Val-Ala-Pro-Gly (VGVAPG, SEQ ID NO: 19), which is highly relevant to elastin research. Furthermore, the claims and description...
3 claims
|
|
US-2016101032-A12016
Although the document does not explicitly mention 'elastin-stimulating activity,' it focuses on specific modified peptide sequences (e.g., HRLKR, RLKRL, including N-acetylation and C-amidation) that...
3 claims
|
|
US-2016129045-A12016
The document explicitly identifies and characterizes core elastin-like peptide sequences (VGVPG) and their specific modifications (e.g., multiblock biopolymer REP: [VGRGD(VGVPG)6]n) used in tissue...
3 claims
|
|
US-2016184384-A12016
The document describes tetrapeptides designed to treat skin conditions strongly associated with extracellular matrix (ECM) degradation, specifically aging skin, striae distensae (stretch marks), and...
3 claims
|
|
US-2016194379-A12016
The document explicitly discusses the therapeutic use of 'tropoelastin or elastin derived peptide' for wound healing and re-epithelialization. This places the content directly within the relevant...
3 claims
|
|
US-2016222077-A12016
The patent claims adiponectin-derived peptides (SEQ ID NOs 1-6) inhibit skin wrinkle formation, explicitly linking this activity to the necessity of forming and maintaining extracellular matrix (ECM)...
3 claims
|
|
US-2016228470-A12016
The document explicitly discloses the synthesis and concentration (25-100 μM) of specific elastin-like peptide sequences and polymers, such as the VGVPG repeat and the complex biopolymer...
2 claims
|
|
US-2016334416-A12016
The document provides specific peptide sequences (e.g., FGPGVV, VPGLGV, IKAPKL) derived directly from human elastin (SEQ ID NO:1). While the patent focuses on detecting these sequences as degradation...
3 claims
|
|
US-2017002047-A12017
The document is a patent describing novel synthetic peptides (e.g., IGVAPG, VGAMPG) and their specific modifications (e.g., N-terminal acetylation) that are claimed to stimulate elastogenesis...
3 claims
|
|
US-2017007662-A22017
The document provides specific tetrapeptide sequences (e.g., IEKM, VEKF) and modifications (lipidation, amidation) intended for treating aging skin and striae distensae (stretch marks). These...
3 claims
|
|
US-2017015885-A12017
The document defines specific Elastin-Like Polypeptide (ELP) sequences and incorporates relevant modifications (DOPA, TOPA, specific tags) based on the VPGXG elastin repeat motif. Although the...
3 claims
|
|
US-2017087211-A12017
The document describes novel polypeptides (HPf, HPfΔC1, HPfΔC2) intended for topical use to improve skin conditions, specifically mentioning 'skin elasticity' and 'skin aging'. These claimed effects...
2 claims
|
|
US-2017087252-A12017
The document lists various peptide sequences (SEQ ID NOs) and modifications (chelating agents, labels) designed to target senescent cells, specifically mentioning the treatment of 'skin wrinkles'...
2 claims
|
|
US-2017157014-A12017
The patent directly proposes and claims specific peptide sequences (X-Pro*-Pro*-Xaa-Y, e.g., Myr-PPL-OH, Myr-PPR-OH) and modifications (e.g., palmitoyle, myristoyle) intended to 'stimulate the...
3 claims
|
|
US-2017182130-A12017
The document identifies specific Elastin-Like Peptide (ELP) sequences (e.g., VPGXG repeats, specific lengths, and composition ratios, SEQ ID NOs 1-13) that are structurally related to elastin. While...
3 claims
|
|
US-2017183386-A12017
This patent lists hundreds of bioactive peptide sequences (SEQ ID NOs 1 to 1312) and claims their use in 'preventing ageing of skin' (Claim 12) and for 'cellular growth promoting activity.' Elastin...
3 claims
|
|
US-2017190747-A12017
The document describes a specific polypeptide sequence (SV82/SEQ ID NO: 2) and explicitly states that it was tested in a skin test to identify 'skin elasticity maintaining effects' and 'skin wrinkles...
3 claims
|
|
US-2017233446-A12017
The document describes fusion polypeptides (e.g., based on SEQ ID NO:41) intended for treating age-related conditions, specifically mentioning 'skin atrophy' and 'wrinkles.' Since the pathogenesis of...
3 claims
|
|
US-2017258931-A12017
The document provides specific short peptide sequences (KVK, RGD, 2-5 residues) and relevant modifications (palmitoylation, conjugation) within the domain of anti-wrinkle/ECM repair cosmetics....
3 claims
|
|
US-2017281508-A12017
The patent claims disclose multiple specific peptide sequences (SEQ ID NO: 1-16) and their concentrations (e.g., 0.000001% to 5%) for improving skin health. Crucially, Claim 3 explicitly includes...
3 claims
|
|
US-2017326089-A12017
The document explicitly relates to compositions designed to stimulate the biosynthesis of elastin, directly addressing the core function required by the research goal. Although the primary claimed...
3 claims
|
|
US-2017368153-A12017
The document describes RGD-containing peptides used for skin wrinkle reduction and promoting collagen synthesis. The background section specifically notes that the dermis contains both collagen and...
3 claims
|
|
US-2018000717-A12018
The patent explicitly claims that the peptidic compounds 'stimulate the synthesis... of elastin.' It provides specific peptide sequences (e.g., Pal-K(P)-HG-OH, Pal-K(Hyp)-HG-OH), length constraints...
3 claims
|
|
US-2018028426-A12018
The document provides a specific peptide sequence (P-113) and quantitative results related to its anti-aging/anti-wrinkle activity through ECM modulation (MMP-9 inhibition/collagen preservation)....
2 claims
|
|
US-2018050224-A12018
The document identifies a specific modified peptide sequence, Palmitoyl Tetrapeptide-7, used in compositions claiming to increase skin elasticity and firming, which is directly relevant to the...
2 claims
|
|
US-2018094137-A12018
The document explicitly deals with Elastin-Like Peptides (ELPs) and cites specific SEQ ID NOs (1-6, 9). Although the primary application described is structural (contact lens component) rather than...
3 claims
|
|
US-2018110713-A12018
The document details specific peptide sequences (ELKLIFLHRLKRLRKRLKRK) and critical modifications (N-terminal acetylation, C-terminal amidation) intended for anti-aging via dermal matrix component...
3 claims
|
|
US-2018208642-A12018
This document describes the structure and sequence of multiple Elastin-Based Polypeptides (EBPs) derived from VPGXG and VPAXG repeats (SEQ ID NOs 1, 2, 20-36, 41-47). Although the primary function...
3 claims
|
|
US-2018258140-A12018
The document is a patent describing specific peptide sequences (KFNLPLGNYKKP, SEQ ID NO: 1) and their complex chemical modifications (R1/R2 groups including C1-C24 alkyl chains and PEGylation)...
3 claims
|
|
US-2018280287-A12018
The document investigates a hydrolyzed peptide extract (Sacha Inchi) used for anti-aging, specifically claiming to increase dermal density, restructure connective tissue, and improve skin elasticity....
2 claims
|
|
US-2018291070-A12018
The patent claims compositions of specific peptides (SEQUENCE ID NO's 1-1312) used in a method for 'preventing ageing of skin' and possessing 'cellular growth promoting activities.' Elastin...
3 claims
|
|
US-2018303880-A12018
The document, a patent focused on skin restoration, cosmetic improvement, and anti-aging, explicitly mentions 'polypeptides' and 'proteins' as active components in the compositions. While the...
3 claims
|
|
US-2018327464-A12018
The document, a patent application, discloses specific peptide sequences (HSP90a, HPf, HPfΔC1, HPfΔC2) and claims their use for 'improving skin conditions' including 'skin elasticity' and 'wrinkles.'...
3 claims
|
|
US-2018333467-A12018
The document explicitly describes Elastin-Like Peptides (ELPs) using specific repeat units (e.g., VPGXG, SEQ ID NOs: 1-13) and defines their structure (e.g., 120 repeat units). Although the patent...
3 claims
|
|
US-2018344608-A12018
The document, a patent, focuses on ultra-low molecular weight keratin peptides (SEQ ID NOs 1-9) specifically for preventing or improving skin aging and wrinkles. This is the exact domain where...
3 claims
|
|
US-2018360720-A12018
The document is a patent disclosing a specific peptide sequence (ProAspSerThrGluAlaLys, SEQ ID NO: 1) and provides experimental evidence in fibroblast cells (CCD-966SK) showing its effect on...
3 claims
|
|
US-2019038541-A12019
The document explicitly identifies a modified peptide, 'palmitoyl tripeptide 38,' which is claimed to 'enhance collagen and elastin' production. This directly relates to the research goal of...
2 claims
|
|
US-2019046599-A12019
The document describes hundreds of specific peptide sequences (SEQUENCE ID NO's 15-775) and explicitly states that these peptides have been shown to have an 'effect on elastin and collagen...
3 claims
|
|
US-2019062405-A12019
The patent relates directly to the use of 'tropoelastin or elastin derived peptide' for biological activity (wound healing/re-epithelialization). Patents are a required source of information for this...
3 claims
|
|
US-2019062404-A12019
The document defines and uses specific Elastin-Like Polypeptide (ELP) sequences (VPGXG repeats, SEQ ID NOs: 1, 2, 3), which are directly relevant structural analogues to elastin fragments studied for...
3 claims
|
|
US-2019083378-A12019
The document discloses a specific modified tripeptide sequence (Oleanoyl-KVK, SEQ ID #1) and explicitly claims its efficacy via 'anti-elastase' properties. This information (sequence, modification,...
3 claims
|
|
US-2019111103-A12019
The document, a patent application, explicitly identifies specific short peptide sequences (Val-Pro-Gly-Gly, Val-Pro-Gly-Ala, Val-Pro) and claims their activity in enhancing elastin production in...
3 claims
|
|
US-2019153030-A12019
The document, a patent application, explicitly identifies specific modified peptide sequences (e.g., Pal-K(Ac)GH, Pal-K(Ac)HG) and claims their use for improving skin elasticity and being active on...
3 claims
|
|
US-2019153045-A12019
The document, a patent application, is focused entirely on novel synthetic peptides (e.g., IGVSPG, VGVMPG) derived from plant sources that mimic the elastin receptor ligand motif (GXXPG) and are...
2 claims
|
|
US-2019169269-A12019
The document defines and claims specific tropoelastin-derived polypeptide sequences (e.g., SEQ ID No. 1, 2, 3, 6, 8) intended for use in tissue regeneration and biocompatible materials. These...
3 claims
|
|
US-2019185528-A12019
The document discloses specific peptide sequences (elasticity motifs, e.g., GPGGA motif of SEQ ID NO: 2, and other Flagelliform/MaSp/MiSp motifs) that are engineered for their elasticity-conferring...
3 claims
|
|
US-2019185523-A12019
The document describes specific polypeptides (referenced via SEQ ID NOs) derived from botulinum toxin binding domains. These polypeptides are explicitly claimed to modulate 'extra cellular matrix...
2 claims
|
|
US-2019247317-A12019
The document provides specific, defined sequences for Elastin-Like Peptides (ELPs) (e.g., G(VPGSG)n(VPGIG)nY) and conjugates (SEQ ID NO: 5-8). While the primary function described is drug delivery...
3 claims
|
|
US-2019284248-A12019
The document lists over 1,300 bioactive peptides (sequences and modifications are mentioned) and explicitly claims 'cellular growth promoting activities' and 'A method of preventing ageing of skin.'...
3 claims
|
|
US-2019321436-A12019
The document, a patent application, describes a large number of specific peptide sequences (e.g., SEQ ID NO's 15-505) and explicitly states that these peptides were tested and 'have been shown to...
3 claims
|
|
US-2020087374-A12020
The document defines numerous peptide sequences (referenced by SEQ ID NOs and structural motifs like PG-domain) that interact with the elastin receptor (EBP). The abstract explicitly states that this...
3 claims
|
|
US-2020109369-A12020
The document identifies a specific peptide (BMP-2) relevant to skin anti-aging and repair, claiming it helps restore skin elasticity and firmness. While it focuses on the production process, the...
3 claims
|
|
US-2020171332-A12020
The patent application explicitly discusses the use of a specific modified peptide, palmitoyl tetrapeptide-7, in compositions intended to increase skin elasticity and reduce signs of aging. This...
3 claims
|
|
US-2020197472-A12020
The document identifies specific peptide sequences (tripeptide-1 and tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate, TAUT) as components of a composition designed to stimulate the...
3 claims
|
|
US-2020222585-A12020
The patent discusses compositions containing elastin peptides prepared via enzymatic hydrolysis and explicitly claims they 'simultaneously and significantly increase the amount of the elastin and...
3 claims
|
|
US-2020268618-A12020
The document identifies a highly modified oligopeptide ('palmitoyl sh-tripeptide-4 amide') used in skin anti-aging and repair formulations. Although the abstract focuses on clinical outcomes...
2 claims
|
|
US-2020282022-A12020
The document provides explicit, detailed structural information (sequence, length, repeating units, and specific amino acid ratios: VPGXG repeats, 90-144 units) for Elastin-Like Peptides (ELPs)....
3 claims
|
|
US-2020360486-A12020
The document details specific amino acid sequences (SEQ ID NO: 1, VPGXG repeats) and their modifications (ELP-C-peptide conjugation, K8/K9 variants) that are tested in a biological system (in vivo/in...
3 claims
|
|
US-2020378971-A12020
The document provides a specific, defined elastin-derived peptide sequence (LPGGYGLPYT) and detailed information on its context (a degradation marker cleaved by PR3), along with assay details...
2 claims
|
|
US-2020392476-A12020
The document explicitly names several peptides relevant to skin aging and extracellular matrix remodeling, including Palmitoyl-KTTKS, Cu-GHK tripeptide, Palmitoyl-GHK, and Palmitoyl-GQPR. These...
2 claims
|
|
US-2021009637-A12021
The patent discloses specific peptide sequences (SEQ ID NOs: 2-15) and explicitly claims their function in "increasing production of elastin." This directly addresses the research goal of identifying...
3 claims
|
|
US-2021054048-A12021
The document, while focused on purification methods for Elastin-like polypeptides (ELPs), explicitly lists specific ELP sequences (e.g., V12, V24, V24-EGF) derived from elastin in Claim 6 (SEQ ID...
1 claim
|
|
US-2021130423-A12021
The document describes defined peptide sequences (HPf, HPfΔC1, HPfΔC2, referencing SEQ ID NOs 1, 20, 21) used in compositions (100 ng/ml to 1 mg/ml concentration) for treating skin conditions,...
3 claims
|
|
US-2021180070-A12021
The document explicitly defines and uses Elastin-Like Polypeptide (ELP) sequences, specifically the general formula (VPGXG)n (Claims 36-38), which are central to the research goal of identifying...
2 claims
|
|
US-2021246165-A12021
The document is a patent for a peptide designed for cosmetic applications, specifically targeting skin wrinkle improvement and increasing collagen expression. Since elastin is a crucial component of...
1 claim
|
|
US-2021277072-A12021
The patent directly describes novel peptide sequences (e.g., acetylated VGAMPG, IGLSPG, and linked multimers) and peptidomimetics designed to stimulate elastogenesis. The document provides specific...
2 claims
|
|
US-2021309722-A12021
The document provides specific peptide sequences for Elastin-Like Polypeptides (ELP), including the general formula (VPGXG)n and specific ratios (e.g., n=120, V:A ratio of 4:1). While the...
3 claims
|
|
US-2021338557-A12021
The document describes specific short peptide sequences (M(O)VV, M(O)₂VV) and required modifications (oxidation, N-acetylation) tested for improving dermatological signs of aging. The claims...
3 claims
|
|
US-2021346458-A12021
The document explicitly claims compositions and methods for 'stimulating elastin and/or collagen production.' It names multiple specific peptides (Tripeptide-1, Hexapeptide-12, Hexapeptide-11, Acetyl...
3 claims
|
|
US-2021353707-A12021
The document, a patent application, describes hundreds of specific peptide sequences (SEQ ID NOs 15-775) derived from pea and rice proteins. The description explicitly states that these peptides...
3 claims
|
|
US-2021379409-A12021
The document explicitly identifies and utilizes specific modified peptides (Palmitoyl tetrapeptide-7 and Palmitoyl oligopeptide) used in topical compositions for improving skin elasticity and...
3 claims
|
|
US-2021395305-A12021
The document describes a short peptide (up to 16 amino acids, Seq ID No. 1, possibly NGF1-14 mimetic) and its chemical modifications (acyl, amido, etc.) for use in treating and preventing skin aging....
3 claims
|
|
US-2021395304-A12021
The document proposes and claims several specific peptide sequences (e.g., SEQ ID NOs 2-15: RPIK, KNAK, PRPIK) and explicitly states their application in 'increasing production of elastin.' This...
3 claims
|
|
US-2022009988-A12022
The document focuses on novel peptides (C-peptide, GxxPG motifs, QDEA motifs) that activate or modulate the 'elastin receptor.' The elastin receptor is the key biological target through which classic...
3 claims
|
|
US-2022023390-A12022
The document defines and tests specific peptide agents (e.g., PB1046, PB1120, and SEQ ID NO: 15) that are described as containing 'one or more elastin-like peptides (ELP).' Although the quantitative...
3 claims
|
|
US-2022049236-A12022
The document provides specific polypeptide sequences (propeptide of LOX, SEQ ID NO: 1 or 5) and associated modifications (e.g., glycosylation, chimeric fusion) that are centrally involved in ECM...
3 claims
|
|
US-2022054388-A12022
The document investigates specific peptide sequences (SEQ ID NO: 1 to 6) for anti-aging and improving skin elasticity/collagen density, which is a highly relevant adjacent domain to elastin...
3 claims
|
|
US-2022098281-A12022
The document investigates the use of 'tropoelastin or elastin derived peptide' for biological application (wound healing/scar treatment). Although the claims focus on the full protein (tropoelastin)...
3 claims
|
|
US-2022151882-A12022
The document is a patent that identifies a specific modified oligopeptide, 'palmitoyl sh-tripeptide-4 amide,' used in anti-aging and skin repair formulations at a defined concentration (0.0001% w/w)....
2 claims
|
|
US-2022233424-A12022
The document identifies specific modified peptide sequences (palmitoyl dipeptide-7 (pal-KT) and acetyl tetrapeptide-11 (ac-PPYL)) aimed at 'ECM repair and renewal processes.' Elastin synthesis is a...
3 claims
|
|
US-2022289801-A12022
The document discloses specific peptide sequences (e.g., PRCWRGEGGGGIVRRADRAAVPGGGGRGD, SDKPGGGGTSLDASIIWAMMQNGGGGLSKL) and a modification (Acetylation mentioned in the abstract) intended for...
3 claims
|
|
US-2022288170-A12022
The document explicitly utilizes Elastin-Like Peptides (ELPs) containing VPGXG repeats (SEQ ID NO: 3 and SEQ ID NO: 15) as part of a therapeutic agent. It provides sequences and quantitative...
2 claims
|
|
US-2022305299-A12022
The document explicitly names a modified peptide, 'palmitoyl tetrapeptide-7,' and associates its use with improving skin elasticity and firmness, which is directly related to the research goal of...
2 claims
|
|
US-2022323534-A12022
The document is a patent describing cosmetic/dermatological compositions targeting skin aging, which involves loss of elasticity and 'elastolysis of elastic fibers' (mentioned in the Description)....
3 claims
|
|
US-2022401343-A12022
The document explicitly identifies a specific modified peptide sequence, Palmitoyl KTTKS (Pal-KTTKS), and claims its utility in 'promoting extracellular matrix synthesis' and 'promoting fibrillin...
3 claims
|
|
US-2022409512-A12022
The document explicitly identifies a relevant modified peptide sequence (Palmitoyl-KTTKS or Pal-KTTKS) and lists its intended biological activity as promoting extracellular matrix synthesis,...
3 claims
|
|
US-2023064303-A12023
The document explicitly identifies a specific modified peptide sequence (Palmitoyl KTTKS, SEQ ID NO. 2) and claims its use in promoting extracellular matrix synthesis, increasing resilience, and...
3 claims
|
|
US-2023089559-A12023
The document is a patent describing compositions containing multiple specific tri-, tetra-, and hexapeptides (including modified forms like Palmitoyl Tripeptide-1, Palmitoyl Hexapeptide-12, and...
3 claims
|
|
US-2023093611-A12023
The document describes the production of recombinant peptides and polypeptides comprising repeat units of amino acids chosen from elastin and its derivatives. Although it focuses on the production...
3 claims
|
|
US-2023121324-A12023
The document discusses methods involving tropoelastin monomers and various isoforms (including those lacking domains like 26A), which are the direct molecular precursors to elastin. It explicitly...
3 claims
|
|
US-2023148647-A12023
The document is a patent claiming a composition for promoting the biosynthesis of elastin, a topic directly central to the research goal. While the primary components listed are individual amino...
3 claims
|
|
US-2023165774-A12023
The document provides specific modified peptide sequences (palmitoyl dipeptide-7, acetyl tetrapeptide-11) and quantitative results (synergy factors, concentrations, ATP assay) tested for improving...
3 claims
|
|
US-2023173030-A12023
The document explicitly utilizes an Elastin-Like Peptide (ELP) component fused with Vasoactive Intestinal Peptide (VIP), referenced by SEQ ID NO: 3. Although the primary function described is...
3 claims
|
|
US-2023173089-A12023
The document describes synthetic peptides (e.g., LQGV, AQGV, and composite structures like ɸn xGxxPG) specifically designed to target the elastin receptor complex (ER). These sequences contain the...
3 claims
|
|
US-2023183289-A12023
The document discloses a specific tetrapeptide sequence (Gly-Gln-Val-Ser) and reports its activity in combating skin aging, specifically through the inhibition of elastase (an enzyme that degrades...
3 claims
|
|
US-2023233438-A12023
The document explicitly identifies specific peptide sequences (KTTKS, GHK) and a crucial modification (palmitoyl-KTTKS) relevant to Extracellular Matrix (ECM) biology. Although it claims 'promoting...
3 claims
|
|
US-2023249008-A12023
The document explicitly names and utilizes a specific modified peptide, 'palmitoyl tetrapeptide 7', for the purpose of 'firming skin' and reducing wrinkles, outcomes directly related to increased...
2 claims
|
|
US-2023255875-A12023
The document, a patent, deals directly with compositions using tropoelastin (the peptide precursor to elastin) and claims the functional outcome of increasing the formation of elastin fibers (Claim...
3 claims
|
|
US-2023302302-A12023
The document explicitly discusses the application and efficacy of a specific modified peptide, palmitoyl tetrapeptide-7. The intended effects (firming skin, increasing elasticity) are directly linked...
3 claims
|
|
US-2023346875-A12023
The document explicitly states that the described compositions and methods are for 'stimulating elastin and/or collagen production.' It lists specific modified peptides (e.g., tripeptide-1,...
3 claims
|
|
US-2023355704-A12023
The document describes hundreds of specific peptide sequences (SEQ ID NOs: 15-775) and explicitly states that these peptides 'have been shown to have an effect on elastin and collagen production and...
3 claims
|
|
US-2023365643-A12023
The document describes adiponectin-derived peptides intended for improving skin wrinkles by promoting extracellular matrix (ECM) components. Elastin stimulation is a core mechanism for anti-wrinkle...
3 claims
|
|
US-2023398049-A12023
Although the primary novel peptides patented focus on collagen/fibronectin stimulation, the background section explicitly sequences and describes the activity of established elastin-stimulating...
2 claims
|
|
US-2023399359-A12023
The document is highly relevant as it explicitly cites and provides the sequence and modification (Pal-VGVAPG, SEQ ID No 3) for a known peptide marketed specifically for its ability to stimulate...
3 claims
|
|
US-2023406896-A12023
The document is a patent application describing compositions containing specific, chemically modified peptides (e.g., Acetyl Octapeptide-17 Amide, Caproyl Tetrapeptide-3) intended for repairing or...
3 claims
|
|
US-2024000898-A12024
The document, a patent, focuses entirely on methods to restore elasticity and form elastin fibers using tropoelastin monomers, variants, or compositions. It explicitly references a Sequence Listing,...
3 claims
|
|
US-2024010677-A12024
The document, while patenting a novel peptide (LLAN), explicitly references and lists previously known modified peptide sequences (Pal-VGVAPG and Ac-YR-hexadecyl ester) and their known function as...
2 claims
|
|
US-2024010682-A12024
The document defines and provides sequences for multiple Elastin-Like Polypeptides (ELPs) and their functional blocks (SEQ ID NOs 003-012). While the stated primary function is hemostasis, the...
3 claims
|
|
US-2024025948-A12024
The document, while focused on peptide adhesives, lists several specific peptide sequences (SEQ ID NOs 26-28) designated as 'elastic conferring sequences' or those that confer 'elastomeric...
3 claims
|
|
US-2024027431-A12024
The document investigates specific peptide sequences (including C-peptide fragments and synthetic peptides defined by SEQ ID NOs) that act as agonists for the 'elastin receptor.' Elastin receptor...
3 claims
|
|
US-2024027466-A12024
Although the document does not report peptide sequences, it details a specific, patented High-Performance Liquid Chromatography (HPLC) method for isolating and quantifying desmosine and isodesmosine....
1 claim
|
|
US-2024043471-A12024
The document describes a tetrapeptide sequence (GQVS) synthesized for 'anti-wrinkle activity.' The patent background explicitly identifies the loss of elastin as a key cause of skin aging and loss of...
3 claims
|
|
US-2024082134-A12024
The document introduces a specific peptide sequence (QHREDGS, SEQ ID NO: 1) intended for skin anti-aging treatments. Claim 2 explicitly states that the peptide's method of use results in 'increasing...
3 claims
|
|
US-2024173237-A12024
The document investigates Fibroblast Growth Factor 17 (FGF 17) for promoting the synthesis of elastin in fibroblasts and references specific figures (FIG. 7) showing quantitative measurements (gene...
1 claim
|
|
US-2024180996-A12024
This patent directly describes compositions and methods for 'stimulating elastin production' and 'stimulating elastogenesis' using specific peptides (tripeptide-1, hexapeptide-12, hexapeptide-11,...
3 claims
|
|
US-2024189477-A12024
The document deals directly with methods for elastic fiber formation (elastogenesis) using fibroblasts and tropoelastin, which establishes the required biological context and methods (cell type,...
3 claims
|
|
US-2024218388-A12024
The document provides a specific sequence (SEQ ID NO: 25, 'partial human elastin') used as a target product. It also reports quantitative outcomes (non-cytotoxicity, increased expression of hHAS2,...
2 claims
|
|
US-2024261204-A12024
The document describes a novel modified peptide (Ascorbic acid polypeptide derivative, specifically EAC-L-carnosine) tested for anti-aging effects, including improving 'skin elasticity.' It provides...
3 claims
|
|
US-2024279276-A12024
The document reports a specific peptide sequence (YLP) and its anti-aging activity, including positive effects on key components of the dermal extracellular matrix (Type I collagen and hyaluronic...
3 claims
|
|
US-2024279277-A12024
The document discloses a specific peptide sequence (GQVS, SEQ ID NO: 1) and its biological activity relevant to dermal structure and elasticity. While the primary mechanism cited is elastase...
3 claims
|
|
US-2024327781-A12024
The document defines specific Elastin-Like Peptide (ELP) sequences (SEQ ID NOs 1, 2, 3, and their multimers) which fall directly within the scope of molecules investigated for elastin-stimulating...
2 claims
|
|
US-2024407993-A12024
The patent claims and description explicitly state that the novel peptide (SEQ ID NO: 1) increases the expression or secretion of elastin in cells (specifically skin fibroblasts), which directly...
2 claims
|
|
US-2024409584-A12024
The document, a patent, directly claims and references data (Claim 7, Claim 8, and the description of Figure 1A) demonstrating that the described peptide (SEQ ID NO: 1) increases the expression of...
2 claims
|
|
US-2024415756-A12024
The patent explicitly claims novel peptide sequences (4-8 amino acids, including variable R1/R2 modifications) that are 'capable of maintaining and/or synthesizing ECM.' Claim 6 further specifies...
2 claims
|
|
US-2025018001-A12025
This patent describes numerous peptide sequences (SEQ ID NOs 1-704) and their chemical modifications intended for use in anti-aging applications by stimulating the biosynthesis of the extracellular...
3 claims
|
|
US-2025025525-A12025
The document, a patent application, lists several specific short peptide sequences (SEQ ID NOs: 1-7, octapeptides derived from elastin/collagen features) and explicitly claims methods using these...
3 claims
|
|
US-2025032532-A12025
The document identifies several specific octapeptide sequences (SEQ ID NOs 1-7) and related peptides (hexapeptide-11, hexapeptide-12) used in topical compositions. Claim 17 explicitly lists one of...
3 claims
|
|
US-2025064707-A12025
The document, specifically Claim 7 and the Description, states that the tested peptide (SEQ ID NO: 1) is part of a composition that 'increases expression or secretion of collagen, fibronectin, or...
2 claims
|
|
US-2025065011-A12025
The document is a patent disclosing explicit sequences of synthetic Elastin-Like Polypeptides (ELPs) (e.g., SEQ ID NO: 11, 12) designed as elastin mimetics for tissue repair. Although the reported...
3 claims
|
|
US-2025074969-A12025
The document claims that the novel recombinant collagen polypeptides (derivatives of SEQ ID NO: 2) have 'elasticity-promoting activities.' Patents that make such claims usually include experimental...
3 claims
|
|
US-2025123275-A12025
The document discusses novel peptides (including specific sequences and modifications like retro-inverso variants and GxxPG motifs) that are designed to agonize the elastin receptor. The elastin...
3 claims
|
|
US-2025171503-A12025
The document discusses and specifies sequences of Elastin-Like Polypeptides (ELPs), such as (VPGXG)m (SEQ ID NO: 34). Although the peptides are used here for purification (based on phase...
3 claims
|
|
US-2025171522-A12025
The document, a patent, explicitly discusses the use of 'tropoelastin or elastin derived peptides' for therapeutic application (wound healing). Patents are a required source for the research goal,...
3 claims
|
|
US-2025197447-A12025
The patent claims a specific peptide (SEQ ID NO: 1) and a composition comprising it increases the expression of 'elastin' (Claim 8) in 'skin fibroblasts' (Claim 6). This directly addresses the...
3 claims
|
|
US-2025188150-A12025
The patent document identifies specific short peptide sequences (e.g., RPKDS, DGKTY) derived from Lysyl Oxidase (LOX) target sites on Extracellular Matrix proteins. Claim 7 explicitly lists the...
3 claims
|
|
US-2025302962-A12025
The document provides explicit, specific sequences (e.g., SEQ ID Nos: 9-13) of highly modified Elastin-Like Polypeptides (ELPs) derived from the VPGXG motif, including complex chemical modifications...
3 claims
|
|
US-2025325638-A12025
The patent addresses the restoration of elasticity using tropoelastin, which is the precursor for elastin, and defines concentrations (e.g., Claim 11: 1 μg/ml to 100 mg/ml) and cell types (Claim 20:...
2 claims
|
|
US-4132746-A1979
The document provides explicit details regarding the sequence, length (10 to 100 units), modifications (Lysine and Glutamic acid substitutions for Val4), and polymerization/cross-linking of synthetic...
3 claims
|
|
US-4589882-A1986
The document explicitly names and claims specific short peptide sequences (e.g., L-Val-L-Pro-Gly-L-Val-Gly and chemotactic fragments like Ala-Pro-Gly-Val-Gly-Val-) used in synthetic bioelastomers....
3 claims
|
|
US-4693718-A1987
The patent discloses specific peptide sequences (e.g., AGVPGFGVG) derived from or related to tropoelastin, which are claimed to stimulate chemotaxis specifically toward 'elastic fiber synthesizing...
3 claims
|
|
US-4870055-A1989
The document identifies and characterizes key peptide sequences (APGVGV, VPGVG, VPGG) derived from tropoelastin, which are the fundamental structural components often tested for elastin-stimulating...
3 claims
|
|
US-4960423-A1990
The document investigates the biological activity of specific complex elastin hydrolysates (α-elastin, K-elastin) at defined concentrations (≈6.2 μg/cm²) on a specific cell type (endothelial cells)....
3 claims
|
|
US-4976734-A1990
The document discloses specific synthetic peptide sequences (e.g., (AGVPGLGVG)n, (AGVPGFGVG)m, H-GFGVGAGVP-OH) that are direct derivatives of tropoelastin repeats. Although the claimed activity is...
3 claims
|
|
US-5064430-A1991
The document defines a family of polynonapeptides structurally derived from elastin/tropoelastin repeating units (VPGX motifs). It explicitly states these peptides 'have increased elastic moduli' and...
3 claims
|
|
US-5336256-A1994
The document utilizes and characterizes specific elastin-derived peptide sequences (e.g., (VPGVG)n and lysine-containing polypentapeptides) which are highly relevant to the research goal. While the...
3 claims
|
|
US-5726153-A1998
The document describes synthetic peptides derived from or 'sufficiently duplicative' of regions of elastin proteins for diagnostic use (Abstract, Claim 20). While the reported activity is vascular...
3 claims
|
|
US-5955055-A1999
The document investigates synthetic peptides that are sequence-duplicative of regions of elastin proteins. Although the reported activity is related to binding/accumulation at injury sites...
3 claims
|
|
US-6069129-A2000
The document, a patent, directly claims and specifies several peptide sequences (SEQ ID NOs 17, 18, 19, 23, including the modified peptide VGV[Hyp]G) that are designed and utilized to 'increase the...
3 claims
|
|
US-6127166-A2000
The document provides specific amino acid sequences (SEQ ID NOS: 6, 7, 8, 9) of glycine-rich peptides (abductin) derived from a highly resilient protein structurally analogous to elastin. It...
3 claims
|
|
US-6423333-B12002
The document utilizes and names specific repetitive peptide sequences derived from elastin, notably GVGVP, and describes their incorporation into biomaterials via modification (lysine/arginine...
3 claims
|
|
US-6506731-B12003
This patent directly describes and claims the use of specific low molecular weight peptides (referenced by SEQ ID 66-75 and a general R1-LGAGGA-G-R2 formula) derived from elastin sequences for the...
3 claims
|
|
US-6620419-B12003
The document defines and claims modified peptides (e.g., Palmitoyl-Lys-Thr-Thr-Lys-Ser, fulfilling the sequence and modification requirements) intended for use in cosmetic compositions against skin...
3 claims
|
|
US-6777389-B12004
The document is a patent focused on therapeutic compositions using elastin-derived peptides (41 distinct SEQ IDs are listed) intended to treat conditions that would benefit from increased elastin...
3 claims
|
|
US-6794362-B12004
The patent directly introduces specific peptide sequences (SEQ ID 55-65) that are claimed to enhance tissue elasticity and turgor, fulfilling the requirement to identify reported peptides tested for...
3 claims
|
|
US-6809075-B12004
This patent focuses on compositions containing specific peptide sequences (referenced by SEQ ID numbers) derived from elastin, claiming they enhance tissue elasticity and appearance. This directly...
3 claims
|
|
US-6858201-B22005
The document describes the use of metal-peptide complexes (Copper(II) and Tin(II)) derived from, or chemically synthesized to replace, elastin hydrolyzates. This directly addresses the research...
3 claims
|
|
US-6906036-B22005
The document describes peptides designed to inhibit matrix metalloproteinases (MMPs) and stimulate cellular proliferation, including fibroblasts. These peptides are explicitly claimed for use in...
2 claims
|
|
US-6962904-B12005
This document (a patent) directly addresses the research goal by listing multiple specific peptide sequences (e.g., GAVVPQ, VVPQ) and their associated chemical modifications (Acetyl, Amide, Cysteine...
3 claims
|
|
US-7001328-B12006
The background section explicitly identifies the crucial elastin-derived cell binding sequence, VGVAPG, and describes its function in suppressing smooth muscle cell phenotypic transition by...
2 claims
|
|
US-7196162-B22007
The document provides specific peptide sequences (SEQ ID NO: 2, 6, 7) intended for anti-aging and promoting healthy skin, addressing issues like wrinkling and degradation of elastin fibers (actinic...
1 claim
|
|
US-7211269-B22007
The document claims that the peptide sequence (Gly-Pro-Gln)n-NH2, along with its terminal amide modification (-NH2) and potential D/L amino acid configurations, is designed to increase the expression...
2 claims
|
|
US-7396815-B22008
The document introduces novel peptide sequences (SEQ ID NO: 1 and 2) explicitly designed to treat cutaneous aging by acting on the extracellular matrix (ECM), specifically listing 'elastin' as one of...
3 claims
|
|
US-7459166-B22008
The document identifies a specific peptide sequence (Palmitoyl-gly-his-lys) and its modification (palmitoylation), which is used in a composition aimed at improving skin elasticity and counteracting...
2 claims
|
|
US-7560430-B22009
The patent directly names and claims specific peptide sequences (PGGVLPG, VGVVPG, IGLGPGGV) that are used in compositions intended to 'stimulate the endogenous synthesis and deposition of Elastin'...
3 claims
|
|
US-7566693-B22009
The document lists 17 specific hexapeptide sequences (SEQ ID NO: 1-17) related to elastin fragments (VGVAPG motifs) that are claimed for use in compositions and methods for 'protecting elastin fibers...
3 claims
|
|
US-7666829-B22010
The document explicitly lists 22 specific GXXPG pentapeptide sequences (SEQ ID NO: 1-22), including variants with hydroxyproline modifications (G3Hyp3HypPG, G4Hyp4HypPG), which are claimed to induce...
2 claims
|
|
US-7674451-B22010
The patent claims the use of specific peptide sequences (RGS variants, (AA)n-Arg-Gly-Ser-(AA)n) and their derivatives/modifications (acetylation, amidation) for treating loss of elasticity and...
1 claim
|
|
US-7700110-B22010
The document describes compositions containing specific modified peptides (e.g., palmitoyl wheat protein hydrolysate, dipalmitoylhydroxy proline, dipeptide diamincobutyroyl benzamide diacetate,...
3 claims
|
|
US-7700126-B22010
The document discusses engineered materials using human recombinant tropoelastin fragments and chemically modified tropoelastin (acetylated, methylated, pegylated, or linked to a peptide linker)....
3 claims
|
|
US-7723308-B22010
The patent claims and describes specific novel peptide sequences (sextapeptides like IGAMPG and their linked dimers) designed to serve as functional ligands for elastin receptors and stimulate...
2 claims
|
|
US-7744932-B22010
The document explicitly names two peptides, 'dipeptide valyl-tryptophane' and 'palmitoyl tetrapeptide-3,' which are used in compositions addressing skin aging, elasticity loss, and sagging....
3 claims
|
|
US-7803522-B22010
The document, a patent, directly identifies and claims the use of numerous specific synthetic elastin peptide sequences (e.g., PGGVLPG, VGVVPG, VGAMPGAAAAAVGAMPG) for stimulating elastogenesis and...
3 claims
|
|
US-7807625-B22010
Discloses specific acylated hexapeptide sequence (Palmitoyl hexapeptide-6/FALLKL) intended for improving the dermal fibroblast matrix and fibroblast regulation. Elastin is a key component of the...
3 claims
|
|
US-7851449-B22010
The document reports a specific peptide sequence (KED) and quantitative activity data related to enhancing vascular wall durability and capillaries resistance, including results from vascular wall...
2 claims
|
|
US-7887858-B22011
The document, focused on cosmetic formulations for skin elasticity and firmness, explicitly names and describes peptides known to act on the dermal extracellular matrix, including 'palmitoyl...
1 claim
|
|
US-7906616-B22011
The document provides specific polypeptide sequences (SEQ ID NOs 6, 10, 14) derived from cleaved DANCE (Fibulin-5), a protein essential for elastic fiber formation (elastogenesis). The patent...
3 claims
|
|
US-8029816-B22011
The document explicitly uses and defines the elastin pentapeptide VGVPG (SEQ ID NO:1) as a block in a copolymer coating for medical devices. It also details relevant modifications and linkages (e.g.,...
3 claims
|
|
US-8048456-B22011
The patent explicitly discloses the composition and use of a modified peptide, 'palmitoyl tetrapeptide-7,' for skin firming and anti-wrinkle treatment. This fits the required criteria of capturing...
3 claims
|
|
US-8097581-B22012
The document provides specific peptide sequences (Phe Ala Leu Leu Lys Leu / Palmitoyl-Hexapeptide-14), modifications (palmitoylation, C-terminal carboxamide), and intended function (rebuilding the...
3 claims
|
|
US-8114829-B22012
The document explicitly lists 17 specific peptide sequences (SEQ ID NO: 1 through 17) used in methods targeting dermal elastic fibers and reducing skin damage, which is highly relevant to identifying...
1 claim
|
|
US-8252740-B22012
The document defines and uses an Elastin-Like Polypeptide (ELP) characterized by the repeating sequence XGVPG (SEQ ID NO: 1). This motif is structurally core to elastin research. Although the patent...
3 claims
|
|
US-8383594-B22013
The document discloses a specific modified peptide sequence (Oleanolic acid-Lysyl-Threonyl-Threonyl-Lysyl-Serine) explicitly aimed at regenerating the dermal matrix and boosting 'other matrix...
3 claims
|
|
US-8461113-B22013
The document reports specific peptide sequences (e.g., PGGVLPG, VGVVPG, IGLGPGGV) and claims their efficacy in stimulating the production of Elastin and related components (fibrillin). This directly...
3 claims
|
|
US-8507441-B22013
The document discloses specific peptide sequences (C-terminal endostatin fragments) with defined lengths and modifications (amidation) that exhibit anti-fibrotic activity by regulating extracellular...
1 claim
|
|
US-8518105-B22013
The document is centered on protein elastin-based polymers (Elastin-Like Polypeptides, ELPs) used in tissue applications (vessel coating) and explicitly lists several required data points, including...
3 claims
|
|
US-8524210-B22013
The document, a patent, directly discloses novel synthetic and plant-derived peptide sequences (e.g., VGAMPG, VGLSPG, and their linked/dimeric versions) that are claimed and described as stimulating...
3 claims
|
|
US-8642578-B22014
The patent explicitly lists 17 specific hexapeptide sequences (SEQ ID NO: 1 through 17, e.g., Val-Gly-Ala-Met-Pro-Gly) that are claimed as 'stimulators of elastogenesis' (Claims 3, 6, 18, 21). This...
2 claims
|
|
US-8673840-B22014
The document identifies a specific polypeptide sequence (Lopap, defined by SEQ ID NO: 1) used as an anti-aging agent. It explicitly claims that this polypeptide increases the expression of...
3 claims
|
|
US-8680246-B22014
The document focuses on Lysyl Oxidase-Like-2 (LOXL2) antibodies and associated peptide epitopes (SEQ ID NO:2: TPAMGLQKK). LOXL2 is a crucial enzyme responsible for the cross-linking and maturation of...
3 claims
|
|
US-8691300-B22014
The document explicitly identifies a specific modified peptide, palmitoyl tetrapeptide-7, which is claimed to increase skin elasticity and firmness. This peptide sequence and its modification...
2 claims
|
|
US-8778376-B22014
The document describes specific elastin-derived peptide sequences (VGVPG, SEQ ID NO:1) and detailed chemical modifications (copolymerization with PEG, PLA, PC, etc.) used in biomedical applications....
1 claim
|
|
US-8808365-B22014
The document, a patent, explicitly lists and claims specific chemically modified tropoelastin molecules (e.g., acetylated tropoelastin, pegylated tropoelastin, methylated tropoelastin) and...
3 claims
|
|
US-8809276-B22014
The document discloses specific synthetic peptide sequences (SEQ ID NOs 1, 2, 3, 5, 6) with defined modifications (C-terminal amidation) that activate 'extracellular matrix protein synthesis' in skin...
3 claims
|
|
US-8828927-B22014
The document explicitly provides specific elastin peptide sequences (PGGVLPG, VGVVPG, IGLGPGGV) and claims their use in methods of stimulating elastin production and enhancing tissue elasticity,...
3 claims
|
|
US-8865651-B22014
The document provides specific sequences and detailed modifications (Palmitoylation, Acetylation) for peptides (SEQ ID NO: 7, 8, Pal-KVK) designed to stimulate dermal extracellular matrix synthesis...
3 claims
|
|
US-8871707-B22014
The patent directly names and lists multiple specific peptide sequences (e.g., PGGVLPG, VGVVPG, various repeat sequences) claimed to function as 'elastogenic agents' to stimulate cultured dermal...
3 claims
|
|
US-8895082-B22014
The document explicitly identifies a specific modified peptide, 'palmitoyl tetrapeptide 7,' used in an application (skin firming/anti-wrinkle) directly linked to extracellular matrix components like...
2 claims
|
|
US-8940868-B22015
The document defines specific Elastin-Like Peptide (ELP) sequences (e.g., YSPGVG, SEQ ID NO:3) which are structural analogs of natural elastin repeats. Although the primary function described is drug...
3 claims
|
|
US-8987212-B22015
The document explicitly identifies a specific peptide sequence (SEQ ID NO: 1) and modification (linked to oleanolic acid) related to the elastin system. Although the primary activity claimed is...
3 claims
|
|
US-9006170-B22015
The document, a patent, directly claims therapeutic compositions using specific peptide sequences (GXXPG variants, including GAAPG, GVVPG, and modified sequences like G3Hyp3HypPG and G4Hyp4HypPG)...
3 claims
|
|
US-9067972-B22015
The document provides specific peptide sequences (NIPPL, VPPF, PVVVP P, etc.) that are structurally related to known elastin-derived peptides, and are designed for skin aging treatment and ECM...
3 claims
|
|
US-9115212-B22015
The document describes bifunctional peptides containing the VGVAPG motif (a known elastokine sequence derived from elastin) which is claimed to bond to an 'elastin-binding receptor protein.' Although...
3 claims
|
|
US-9125843-B22015
The document lists specific synthetic peptide sequences (SEQ ID 1-8) along with their modifications (amidation, -NH2) and application concentrations in the relevant domain of skin anti-aging/ECM...
3 claims
|
|
US-9127047-B22015
This document defines and uses various lengths and compositions of Elastin-Like Peptides (ELPs) (e.g., VPGXG repeats) as fusion proteins. While the stated function in the patent is half-life...
3 claims
|
|
US-9254300-B22016
The document explicitly identifies a specific peptide sequence (Val-Gly-Val-Ala-Pro-Gly / SEQ ID NO: 19) and claims its use in a composition designed to increase the deposition of insoluble elastin...
3 claims
|
|
US-9314488-B22016
The document describes methods for restoring aged or damaged skin using cellular extracts that contain 'purified nucleic acids, polypeptides, lipids, carbohydrates or other natural products.' Skin...
1 claim
|
|
US-9375395-B22016
The document is highly relevant to the core activity being researched (tropoelastin promotion/elastin-stimulating activity) and discusses quantitative outcomes related to this mechanism. While the...
3 claims
|
|
US-9422334-B22016
This patent directly describes and claims novel synthetic and plant-derived peptide sequences (e.g., IGVAPG, VGVAPGAAAAAVGVAPG) specifically designed and claimed to stimulate elastogenesis and act as...
3 claims
|
|
US-9458197-B22016
The patent directly addresses the research goal by identifying specific elastin peptide sequences (PGGVLPG, VGVVPG, IGLGPGGV) that are claimed to stimulate the endogenous production of Elastin and...
3 claims
|
|
US-9475857-B22016
The patent claims therapeutic use for age-related conditions affecting the skin, specifically listing 'skin atrophy' and 'wrinkles.' These applications often rely on modulating extracellular matrix...
3 claims
|
|
US-9624286-B22017
The document identifies novel peptide sequences (SEQ ID NOs 1-6) designed to promote extracellular matrix (ECM) formation and reduce skin wrinkles. The Background Art section specifically highlights...
2 claims
|
|
US-9682118-B12017
The document contains detailed definitions of specific Elastin-Like Polypeptide (ELP) sequences (VPGXG repeated 30-200 times) and their fusion with various CPPs, which are central to the structural...
3 claims
|
|
US-9693947-B12017
The document explicitly states that the composition includes anti-aging peptides (specifically identifying Oligopeptide-24) intended to 'enhance collagen and elastin.' This directly addresses the...
1 claim
|
|
US-9815878-B22017
This patent discloses specific synthetic peptide sequences (SEQ ID NOs 1-9) of defined lengths (20-39 mers) and modifications ('MO'). These peptides are claimed to stimulate collagen synthesis and...
3 claims
|
|
US-9833642-B22017
The document explicitly identifies a modified peptide sequence (Palmitoyl tetrapeptide-7) used in compositions claiming to firm skin and increase elasticity. Elastin stimulation is a primary...
3 claims
|
|
US-9850278-B22017
The document reports on short synthetic peptides (FKE, YKE) and their modifications (acetylation, amidation) used to inhibit inflammation-induced fibrosis and scar formation. Although the primary...
3 claims
|
|
US-9872825-B22018
The document reports specific peptide sequences (ELKLIFLHRLKRLRKRLKRK) and critical modifications (N-acetylation, C-amidation) tested for anti-aging effects through ECM remodeling (fibroblast growth,...
3 claims
|
|
US-9879060-B22018
The research goal seeks peptides tested for 'elastin-stimulating activity.' This patent describes a specific polypeptide (SV82, SEQ ID NO: 2) used in a cosmetic composition for 'reducing skin...
3 claims
|
|
US-9956263-B22018
The document is a patent describing novel polypeptides (HPf, HPfΔC1, HPfΔC2, identified by SEQ ID NOs) used in topical formulations specifically for improving 'skin elasticity' and 'skin aging.'...
3 claims
|
|
US-9999649-B22018
The document reports detailed quantitative results for a specific modified peptide (Pal-YIGSR) and unmodified peptide (YIGSR) regarding Extracellular Matrix (ECM) synthesis (collagen) in dermal...
3 claims
|
|
US-9999639-B22018
The patent addresses improving skin health and restoring aged skin using agents that include 'purified or synthetic nucleic acid sequences, polypeptides, or natural products contained in the...
3 claims
|
|